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ABSTRACT OF THE DISSERTATION

Effect of California Mission Fig Consumption on Level of C-Reactive
Protein and Antioxidant Levels
By
Rasha Abdrabou
Doctor of Public Health Candidate in Preventive Care
Loma Linda University, 2009
Serena Tonstad, MD, MPH, PhD, Chair
Susanne Montgomery, MS, MPH, PhD, Co-Chair

Polyphenols exert anti-inflammatory and antioxidant effects. We investigated the effect
of consumption of polyphenol-rich figs on high sensitivity C-reactive protein (CRP) and
antioxidant levels in hyperlipidemic subjects. The purpose of this study was to examine
the effect of fig consumption on C-reactive protein and antioxidant levels. Analyses were
carried out on collected data from September to December of 2008. Using a crossover
design, one hundred and two participants were recruited and randomized into an
intervention phase (eating figs) and a control phase (not eating figs) for 5 weeks. Blood
samples were drawn from each group at the 4th and 5th week of each phase, centrifuged
and frozen. Frozen samples were sent to the University of California Davis Clinical
Laboratories for CRP analysis. Antioxidant analysis was done on frozen samples in the
Nutrition Laboratory at Loma Linda University via a test and retest method for accuracy
using the ferric reducing antioxidant power (FRAP) and total antioxidant capacity
(ABTS) tests. Data was analyzed using SPSS for paired t-test analysis for CRP,
m

antioxidant tests and dietary recalls. Mean CRP values did not differ significantly in the
intervention phase when compared to control phase (median [interquartile range] 1[0.5,
2.1] mg/L versus 1 [0.6, 2.1]; p=0.31). The FRAP test results did not differ between study
phases (0.1+ 0.1 mmol versus 0.1+ 0.1 mmol; p = 0.96). The ABTS test concentrations
likewise did not differ between the two phases (0.2+ 0.04 mmol versus 0.2+ 0.04 mmol;
p= 0.97). An analysis of dietary intake showed participants consumed approximately 187
calories more in the intervention phase (pO.OOOl) while consuming 4% less calories
from fat (pO.OOOl). For men and women with elevated cholesterol levels, fig
consumption did not lower CRP or affect antioxidant levels. While overall intake of iron,
magnesium, potassium and copper increased significantly, fat and protein intake
decreased slightly despite higher caloric intake.
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CHAPTER 1
INTRODUCTION

A. Statement of the Problem
Cardiovascular disease (CVD) has been the leading cause of death in both women
and men since the year 1900, with the exception of the 1918 influenza epidemic
(American Heart Association [AHA], 2007). Cardiovascular disease is a group of
conditions that include heart disease, stroke, high blood pressure, heart failure and several
others and in 2004 was identified as the underlying cause of death in 869,724 people
(AHA, 2007). When considered separately from other CVD risk factors, such as diabetes
and hypertension, coronary artery disease was the leading cause of death, claiming
451,326 lives, while stroke was the third leading cause of death nationally with 150,074
deaths in 2004 (AHA, 2007).
Although the number of deaths to CVD were lower in 2004 than 2003 and have
been declining since 1999, overall the numbers are still staggering and the risk factors
that cause the disease are on the rise (AHA, 2007). These risk factors, which are mostly
lifestyle related and can drastically alter risk if modified, include high blood pressure,
high cholesterol, diabetes, smoking, physical inactivity, and obesity. According to the
Centers for Disease Control and Prevention (CDC), 37% of adults have at least two of
these risk factors (CDC, 2003). Rates of overweight, for example, are on the rise in both
adults and children and have been rising for several decades (AHA, 2007). Overweight
in adults is defined as a BMI range of 25-29.9kg/m while obesity is defined as a BMI
value of 30kg/m2 and greater (CDC, 2009). Overweight and obesity in children are
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classified according to a growth chart and a percentile range. Children in the 85

th

percentile and less than the 95th percentile are considered overweight while those in the
95th and higher percentile are considered obese. According to recent statistics, 66% of
adults are overweight, while 31.4% of children are obese (AHA, 2007). Among children
and adolescents, 12-19 years of age, 17% are overweight, while the percentage of
overweight among those between ages 6-11 and 2-5 are 17.5% and 14%, respectively. A
staggering 90% of middle aged Americans will develop hypertension in their lifetime, of
whom 65% will not be able to keep it within normal ranges. CVD also includes some unmodifiable risk factors, such as age, gender, family health history, and race (AHA, 2007).
The damage caused by CVD extends beyond human loss to healthcare cost. Cost for
heart disease and stroke is expected to exceed $448.5 billion in 2008, of which $152.1
billion alone is due to loss of productivity (Centers for Disease Control [CDC], 2008).
Hypertension treatment spending reached $69.4 billion in 2008, while among Medicare
beneficiaries cost of hospitalization reached $29 billion in 2001 (CDC, 2008).
These risk factors, although diverse, have a common effect on the endothelial
function of the heart (Vita, 2005). Endothelial health plays a key role in regulating the
development of atherosclerosis, which is the underlying cause of all heart disease (Vita,
Keaney, 2002). Atherosclerosis, a chronic inflammatory disease characterized by plaque
formation in medium sized arteries, can be present for years before it manifests itself in a
variety of CVD forms, such as MI or even sudden cardiac death (Ross, 1999). According
to Ross (1999), these cardiac events usually occur when plaque is exposed to flowing
blood as a result of a ruptured artery. Even though the exact mechanism of action is not
well understood, local inflammation within the plaque is considered an important factor
2

(Libby, 1995). Plaque formation and eventual development of CVD affect the
homeostatic balance of the vascular system by producing factors that act on the vessel
wall, as well as the lumen. Other endothelium derived products that affect vascular
homeostasis are fibrinolytic factors, substances that influence vascular tone, as well as
factors that affect coagulation and pro inflammatory factors, to name a few (Widlansky,
Gokce, Keaney, Vita, 2003). These observations lead to the conclusion that the state of
the endothelium is directly related to vascular health and thus is implicated in the
development of CVD. Therefore, maintaining a healthy endothelium will have a great
impact not only on heart disease rates, but will indirectly impact healthcare costs.
The environment, genetics, and diet are all factors affecting the extent of the
influence CVD risk factors have on endothelial function (Leeson, Hingorani, Mullen, et
ah, 2002). According to the American Heart Association, CVD risk reduction requires
maintaining an ideal body weight, monitoring lipid levels, and maintaining an exercise
program for 30-60 minutes on most days of the week. Proper nutrition is also vital in
achieving ideal weight, but obesity rates nationwide reflect a grim picture of our ability to
do so. Data from the 2005 Behavioral Risk Factor Surveillance System (BRFSS)
established that fewer than one in three U.S adults consume fruit two or more times per
day and only 27.2% ate vegetables three or more times per day (CDC, 2007). The USDA
guidelines for consumption of fruits and vegetables for adults recommend the equivalent
of 2 cups of fruit and 2 and a half cups of vegetables per day (USDA, 2005). Despite the
well documented benefits of eating fruits and vegetables and the association with
decreased risk of chronic disease (USDA, 2005), Americans are still reluctant to increase
their intake of these nutrient-dense foods. In 1999, only 17% of 15,000 Americans
3

surveyed from different stages of life ate the recommended servings (Thompson, et ah,
1999).
Although benefits of nutrient-dense fruits and vegetables have been credited
largely to their high content of vitamins and beta carotene, recent studies have attributed
greater benefits to their phenol antioxidant content, both monophenols and polyphenols
(Yusuf, Dagenais, Pogue, Bosch, & Sleight, 2000; Ascherio, et ah, 1999). Apples, for
example, have high levels of phenols in the form of flavonoids, and according to a long
term Finnish study conducted on 10,000 men and women, were linked to a decrease in
the risk of lung cancer in that population (Knekt, Jarvinen, Seppanen, & Hellovaara,
1997). Flavonoids and other phenols, such as proanthocyanidins and phenolic acids,
have been shown to have anticancer effects (Seeram, 2008), as well as being protective
for heart disease (Hertog, Feskens, Hollman, Katan, & Kromhout, 1993) and stroke (Keli,
Hertog, Feskens, & Kromhout, 1996). Berries, also rich in polyphenols, also have been
shown to have anticancer effects (Seeram, 2008).
The significance of the effect of phenol oxidants on decreasing the risk of several
chronic and lifestyle diseases makes them a worthy candidate for further studies.
Polyphenols are not only the most abundantly available antioxidants, they also can be
ingested in higher amounts (Scalbert, Johnson, & Saltmarsh, 2005). Intake can be as high
as Ig/d, an amount 10 times higher than the intake of vitamin C (Scalbert, Johnson, &
Saltmarsh, 2005), for example. Flavonoid consumption from tea, apples and onions
among 805 elderly men from the Zutphen Elderly study yielded a 68% decrease in
cardiovascular risk among those consuming more than 29mg/d (Hertog et al., 1993).
Another study assessed the relationship between consumption of tea and coffee and the
4

incidence of myocardial infarctions among participants of the Boston Area Health Study
(Sesso et ah, 1999). Among those who drank more than one cup of tea a day, there was a
44% reduction in cardiovascular events (Sesso et ah, 1999). Polyphenols also
demonstrated benefits among individuals with established cardiovascular disease. The
Myocardial Infarction Onset study demonstrated that moderate and heavy tea drinkers
reduced cardiovascular risk by 31% and 39% respectively, after adjusting for other risk
factors (Mukamal, Maclure, Muller, Sherwood, Mittleman, 2002). The study included
1900 participants who were hospitalized for acute myocardial infarctions (Mukamal,
Maclure, Muller, Sherwood, Mittleman, 2002).
B. Purpose of the Study
Since costs associated with cardiovascular disease extends beyond the material
loss to the devastating loss in human life, finding a treatment that is cost effective and
available to most individuals is most essential. Oxidative stress and inflammation are two
processes implicated in the development of CVD. Though not all research has been
supportive of their effect or clear regarding the action pathway, enough studies have
established a relationship to warrant further investigation into the matter.
Inflammation is the process by which the body signals the presence of injury or
infection. Factors such as cigarette smoking, hypertension and obesity all signal a release
of chemicals, such as cytokines, and the activation of the inflammatory process that
eventually leads to the formation of plaque and blood clots (AHA, 2007). Inflammation
then manifests itself through production of markers such as C-reactive protein (CRP;
Patrick & Uzick, 2001). Inflammation plays a critical role in the development of
atherosclerosis through the accumulation of monocytes and T-cells in the endothelium of
5

the vessels that eventually proliferate and differentiate, forming lesions and fibrous caps
(Van Dyke, & Komman, 2008).
Patients with immune-inflammatory diseases have been shown to have a higher
risk of mortality and morbidity due to cardiovascular disease (Wilson, 2008). This higher
risk was not found to be associated with a higher rate of traditional risk factors such as
hypertension and hyperlipidemia, but to nontraditional ones such as levels of
inflammatory markers (Wilson, 2008). Evidence in the current literature support the use
of CRP as a tool in the assessment of CVD (Patrick & Uzick, 2001) as a part of a group
of markers that researchers are shifting towards assessing to improve global
cardiovascular risk prediction (Torres & Ridker, 2003). CRP has been shown to predict
future risk of cardiovascular disease at a wide range of values of low-density lipoprotein
cholesterol, Framingham Risk Score and metabolic syndrome and even among healthy
women and men, CRP enabled the stratification of individuals into low, moderate and
high risk of CVD (Torres, Ridker, 2003).
A study conducted in Denmark among individuals without major CVD at baseline
demonstrated that CRP is significantly related to the risk of developing CVD later in life
(Jeppesen, et al. 2008). Based on a study conducted in China, Li and Fang (2004)
concluded that CRP can no longer be thought of as playing a passive role in CVD
prediction, but that it is a direct cause of CVD and that treatments reducing CRP should
be used for both primary and secondary prevention of the disease. This conclusion was
due to evidence presented through data showing that monocytes increased production of
interleukin-6 (IL-6) in response to CRP, which was inhibited by the ingestion of a statin
drug.
6

In another study conducted on 17,802 men and women with normal blood lipid
levels and elevated CRP, ingestion of rosuvastatin reduced CRP levels and in turn
significantly decreased the occurrence of cardiovascular events (Ridker, 2008). From the
evidence provided by the literature, it is clear that CRP is a strong predictor of heart
disease among healthy individuals and that it should serve as a global assessment tool to
prevent future incidence of CVD. Statins were not the only interventions researched by
the scientific community for their effect on CRP levels. Studies examining the effect of
dark chocolate rich in flavnols, a subclass of polyphenols, versus white chocolate without
flavnols on blood pressure and insulin sensitivity found an improvement in both
measurements in healthy individuals (Grassi, et ah, 2005). Polyphenol-rich wine has
long been thought of as heart protective. According to recent studies, polyphenols in
wine stimulate eNOS production, a heart-protective enzyme (Wallerath, 2005). In a
literature review of epidemiologic studies on the health benefits of polyphenols and their
effect on cardiovascular function, researchers concluded that though there were
inconsistencies in the human data reported, the studies still showed a reduction in
inflammatory markers when foods rich in polyphenols were ingested (Vermuri, Kelley, &
Erikson, 2008). Cherries, for example, when ingested by healthy participants for 28 days
yielded a 25% decrease in CRP levels (Kelley, Rasooly, Jacob, & Kader, 2006).
In a study conducted in Scranton, Pennsylvania, researchers sought to determine
the amount and quality of phenol antioxidants in dried fruit compared with fresh fruit
(Vinson, Zubik, Bose, Samman, & Proch, 2005). As a dried, concentrated form of the
fruit, researchers sought to investigate how the quality, as well as the quantity, of phenol
antioxidants would differ between the dried and fresh apricots, cranberries, dates, figs,
7

raisins and prunes (Vinson et al., 2005). The analysis of the data showed that dates had
the highest concentration of polyphenols, while figs and dried plums had the best nutrient
score among the dried fruit, as well as a higher quality of antioxidants (Vinson et ah,
2005).
Among the dried fruit tested, figs were shown to enrich lipoprotein plasma and
protect against oxidation for up to 4 hours after consumption (Vinson, et al., 2005). Figs
were also shown to overcome inflammation caused by consuming a carbonated beverage,
and when ingested, figs are in vivo antioxidants (Vinson, et al., 2005). Thus figs, with
their higher quality phenols, are the most suitable fruit to use for further study of the
effect of phenol oxidants on inflammatory processes in the human body.
C. Research Questions
•

What is the effect of fig consumption on CRP levels in the body?

•

What is the effect of fig consumption on antioxidant levels in the body?

D. Theoretical Justification
Polyphenols exert both an anti-inflammatory and an anti-oxidant effect on the
body that ultimately affect risk of cardiovascular disease. One mechanism of action for
the antioxidant effect of polyphenols is thought to be through a decrease in oxidized LDL
levels. The anti-inflammatory effect of polyphenols has not been studied extensively and
therefore an established mechanism of action is not available for use. The hypothesized
connection is based on available experimental data only. Figs are a rich source of
polyphenols and are easily available to the public. If figs indeed affect levels of
inflammation as well as oxidative stress in the body then they would have important
treatment as well as prevention implications.
8

The method employed to assess the effect of polyphenol-rich figs on oxidative
stress and inflammatory processes in the body was a randomized crossover design. The
randomization eliminates any calendar time effect as well as confounding between the
groups. The crossover design allows for repeated testing on the individual in both
conditions (eating and not eating figs) with each participant acting as their own control,
thus requiring a smaller sample size to achieve an adequate level of precision. Multiple
measurements on the same individual produces results that may vary but the variation
found within an individual’s measurements is less than that found between individuals in
a group. The minimized variability allows for a more precise comparison of differences.
Antioxidant levels will be assessed using two methods to ensure accuracy and
consistency of results in the Nutrition Laboratory at Loma Linda University. The ferric
reducing antioxidant power (FRAP) test is highly reliable, fairly inexpensive and easy to
conduct (Benzie & Strain, 1999). The total antioxidant (ABTS) test is also fairly
inexpensive, fast and highly reliable (Re et ah, 1999). Reagents involved in both tests are
easy to prepare. C-reactive protein was tested in laboratories at the University of
California at Davis.
E. Significance to Preventive Care
Initially, inflammation is a transitory condition, but often it becomes chronic
leaving the body vulnerable to a host of diseases and conditions, such as diabetes, heart
disease and much more. Measuring inflammation in the body will help identify those
who are at risk for developing disease, which will serve as an integral part of prevention.
Identifying natural foods that can affect inflammation levels in the body is vital for a
preventive care practitioner in that it will be an effective and simple tool to ward off
9

disease. Polyphenols also have an antioxidant effect in which they have shown to reduce
oxidative stress in the body and provide vascular protection (Stoclet, et ah, 2004). Figs
are inexpensive to grow and are available worldwide. If figs indeed decrease
inflammation and oxidative stress in the body, they will provide a simple and more cost
effective treatment for many diseases at the same time. Rather than addressing
conditions such as diabetes, heart disease, and Alzheimer’s individually, figs can be a
way to treat several at the same time. In the field of prevention, figs reducing
inflammatory marker levels in the body, as well as the damages caused by oxidative
stress could be a valuable assessor for lifestyle diseases that would ultimately result in
reducing health care costs and rates of cardiovascular disease. This has international
implications as well, since figs can be grown in a variety of climates, making them
accessible to many developing, as well as developed, countries.
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CHAPTER 2
LITERATURE REVIEW

A. Overview
1. The Epidemic of Cardiovascular Disease (CVD)
Cardiovascular disease, which includes coronary heart disease (CHD),
stroke, and peripheral artery disease, claims the lives of approximately 700,000
Americans every year, therefore accounting for almost 29% of all deaths (CDC, 2008).
Coronary heart disease is the most prevalent cardiovascular disease, followed by stroke
(CDC, 2008). The American Heart Association’s goal of reducing death rates from these
two leading cardiovascular diseases by 25% by the year 2010 is proving to be attainable.
Although much of the progress made can be attributed to advances made in medicinal
therapies (Capewell, Beaglehole, Seddon, & McMurray, 2000), the progress achieved in
decreasing the rates of disease is diminished by the fact that the underlying risk factors
for CVD are still on the rise (AHA, 2007).
2. Establishing the Risk Factors for CVD
Three major observational studies conducted over a prolonged period of
time sought to determine the risk factors that lead to CVD. These studies include the
Framingham Study, the Multiple Risk Factor Intervention Trial (MRFIT), and the
Chicago Heart Association Detection Project in Industry. The Framingham Study
assessed the lifetime risk of developing CVD in a sample of approximately 7,733
participants that were initially free from disease and ranged in age from 40-94 years
(Lloyd-Jones, Larson, Beiser, & Levy, 1999). The Chicago Heart Association Detection
11

Project in Industry followed a sample of 38,642 participants, all of whom were working
adults ages 18 to 59, and the Multiple Risk Factor Intervention Trial (MRFIT) consisted
of 347, 978 men ages 35 to 57 years and a population-based sample of 3,295 men and
women ages 34 to 59 years (Greenland, et ah, 2003). Collectively these three
longitudinal studies included 380,000 participants, of whom 21,000 participants died as a
result of CVD (Greenland, et ah, 2003). Follow-up lasted 21 to 30 years across the
studies. Risk factors for CVD were determined to be total cholesterol (>240 mg/dL;
>6.22 mmol/L), systolic blood pressure (>140 mmHg), diastolic blood pressure (>90
mmHg), smoking, and diabetes. Excluding smoking, all other risk factors identified can
be directly impacted by nutrition.
The worldwide INTERHEART study, which included participants from 52
countries, identified nine modifiable risk factors that accounted for 90% of all MI events.
These nine risk factors included smoking, dyslipidemia, hypertension, diabetes,
abdominal obesity, psychosocial factors, daily consumption of fruits and vegetables,
regular alcohol consumption, and regular physical activity (Yusuf, et ah, 2004). In
another report released by the American Heart Association, age, gender, family history,
obesity and physical inactivity were all determined by other studies also to be risk factors
for CVD. Although most of the risk factors that cause CVD can be modified through
proper dieting and exercise alone, a few, such as family history, age and gender, require
the addition of medicinal therapies to effect change.
Cardiovascular risk factors affect both genders, but at different rates and vary by
age. For example, incidence of heart disease is 50% higher in diabetic women than in
diabetic men (Huxley, Barzi, & Woodward, 2006). More women than men who have
12

CVD have a family history of the disease (Sullivan, et ah, 1994). Incidence of heart
disease was also shown to be greater among the offspring of the Framingham Study
participants when at least one of the parents had a history of heart disease (Lloyd-Jones,
et ah, 2004). Smoking also poses a greater risk for women than men, having been linked
to approximately half of all coronary events occurring in this group (Rich-Edwards,
Manson, Hennekens, & During, 1995). Hypertension is a major risk factor for developing
heart disease, and according to the Chicago Heart Association Detection Project in
Industry study, young adult males’ elevated blood pressure readings were significantly
related to death from a coronary incident (Miura, et ah, 2001).
According to the National Health and Nutrition Examination Survey, (NHANES)
obesity rates have increased 15-30% between the years 1960 and 2000 (Gregg, et ah,
2005). Weight plays a significant role in controlling blood pressure and lipid levels.
Excess weight has been shown to promote atherogenic risk factors such as
hyperlipidemia, and physical inactivity worsens the outcome while speeding the disease
process (Hung, Whitford, Parsons, & Hillman, 1990). Men who began a vigorous or
moderate exercise program resulted in decreased rates of mortality due to heart disease
(Paffenbarger, et ah, 1993).
3. C-reactive Protein and CVD
C-reactive protein (CRP), an inflammatory marker, has been implicated in
the development of heart disease and has been used as a tool to predict the occurrence of
a first myocardial infarction (MI), ischemic attack or peripheral arterial disease in healthy
men and women (Ridker, Glynn, & Hennekens, 1998). Levels of CRP are affected by
many factors including disease, exercise, and weight (Libby, Bonow, Mann , Zipes
13

,2007). Individuals with CRP levels less than or equal to l.Omg/L are considered low risk
for developing CVD, while those with levels between 2.0mg/L and 3.0mg/L are at
moderate risk and those with levels greater than 3.0mg/L are considered high risk (Libby,
Bonow, Mann , Zipes ,2007) According to Ridker et ah, (1998), results from the
Physician’s Health Study demonstrated the importance of C-reactive protein levels in
predicting incidence of heart attacks. In the 9 year follow-up study, baseline levels of
CRP were measured for a sample of 245 participants who developed a first MI and 372
participants who never developed the disease. Those who had elevated levels of CRP at
baseline had a higher risk of developing an MI. In another study conducted in Augsburg,
Germany, Koenig and colleagues (1999) examined the association between CRP levels
and the incidence of a first major CVD event in 936 men ages 45 to 64 who were
randomly selected from the general population. Data for the Monitoring Trends and
Determinants in Cardiovascular Disease (MONICA) survey was collected from 1984 to
1985 and the participants followed for 8 years. The investigators concluded that there was
a statistically significant positive correlation between CRP values and CVD incidence in
the population.
The Framingham Score provides a way to assess cardiovascular disease risk
together with borderline values of blood pressure, pre-diabetes, and lipid levels (Vasan, et
ah, 2005). CRP alone or in combination with any risk factors was found to be a better
predictor of cardiovascular events (Kervinen et al., 2001). In the Helsinki Heart Study
conducted in Finland, Kervinen et al. (2001) measured baseline and pre-cardiac event
CRP levels in men with elevated lipid levels who eventually developed heart disease
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during the 8.5 year follow-up. Results showed higher CRP levels in those who developed
the disease versus those in the control group.
4. Polyphenols
Despite making strides in understanding risk factors for CVD, practical
change has been slow to occur, which can be attributed mainly to the fact that
modification of most of the risk factors requires a major commitment to behavior
modification. Nutrition plays an important role in the etiology of CVD since it is
implicated in most of the risk factors that cause a myriad of cardiac diseases. The
scientific community has made many advances in understanding the importance of
nutrition not only in the treatment, but the prevention of CVD (Kris-Etherton & Keen,
2002).

Moving from examining macronutrients and whole foods, scientists are now
making advances in examining the effects of the different bioactive factors in foods and
how they affect health (Kris-Etherton et ah, 2002). Polyphenols, which are natural
compounds abundant in plant foods, have received a lot of attention of late. According to
a report published by Ray Sahelian, MD (2008) on the health benefits of polyphenols,
they are large molecules that are widely distributed in food. Polyphenols are ingested in
greater amounts than other substances with similar effects, with consumption being
usually around Ig per day. Vitamin C and E’s intake, for example, is often at about
lOOmg per day.
Rich sources of polyphenols in the American diet include onions, cocoa, tea,
apples, soy and red wine. Polyphenols are classified into two main groups: phenolic
acids and flavonoids. Phenolic acids account for about a third of all ingested
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polyphenols, while flavonoids account for the remaining two thirds. Phenolic acids are
widely distributed in plants as simple molecules, such as caffeic acid, which is available
abundantly in coffee. Other simple molecules within the phenolic acid group include
vanillin AND courmaric acid, as well as widely distributed groups such as
hydroxybenzoic acid, which occurs mainly as glucosides and hydroxycinnamic acids that
most often occur as simple esters.
Flavanoids, which are the most widely distributed form of polyphenols available
in nature, consist of several subgroups. Anthocyanins, a subgroup of flavonoids, are a
group of large molecules that give different fruits and vegetables a variety of red to
purple pigmentations. Grapes and especially berries have a high content of anthocyanins,
while proanthocyanidins are found in grapes, red wine, and pine bark. Another subgroup
of flavonoids are flavonols or catechins, which are abundantly found in tea, as well as
grape seeds and cocoa. Broccoli has the highest concentration of flavonols, but they are
also available in onions, apples, red wine and tea in high concentrations. Isoflavones are
available in soy and have been shown to mimic the hormone estrogen on post
menopausal women. Each of the above mentioned subgroups has many other
phytochemicals within them, which is a testament to the wide distribution of each of the
polyphenols in plant foods.
B. Antioxidant Effect of Polyphenols
1. Role of Oxidative Stress in Cardiovascular Disease
Several studies have examined the effect of polyphenols on the incidence
of cardiovascular disease through an antioxidant pathway. Oxidative stress has been
shown to play a critical role in causing endothelial dysfunction, which leads to
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atherosclerosis (Davignon & Ganz, 2004). According to Steinberg, Parthasarathy,
Carew, Khoo and Witztum (1989), high plasma levels of low density lipoproteins (LDL)
accumulate into the arterial intima which are then oxidized, forming fatty streaks that
result in endothelial injury. The injury to the endothelium causes adherence of blood
platelets and the eventual release of platelet-derived growth factor, which together with
other growth factors causes cell proliferation and the formation of lesions.
2. Antioxidant Effect of Vitamin C
Antioxidants protect against the oxidization of LDL in the vascular cells
(Steinberg et ah, 1989). A few substances have been identified as antioxidants, and
previous studies have linked an increase in antioxidant levels to a decrease in the risk of
developing CVD, but the mechanism of action is not yet understood. Vitamin C, for
example, has been shown to reverse oxidative stress induced by smoking (Harats, et ah,
1990). In a study conducted by Weber, Erl, Weber, and Weber (1996), plasma levels of
vitamin C were decreased among smokers while such a difference did not exist with
retinol, vitamin E or beta carotene levels. Supplementation with vitamin C restored
normal plasma concentrations and led to a decrease in monocyte adhesion with the
endothelium. The NHANES study found a 34 percent decreased mortality rate among
11,500 American adults consuming 50mg or more of vitamin C a day than those
consuming less than that amount (Enstrom, Kanim, & Klein, 1992). Unfortunately, not
all studies concluded positively on the impact of vitamin C on CVD risk reduction, and
some studies did not find any significant benefit of the vitamin on the disease. Rimm et
ah (1993) studied 39,910 male health professionals who ranged in age from 40-75 years
and who were free of diagnosed heart disease, diabetes and hyperlipidemia to assess the
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impact of vitamin C intake on the development of heart disease. After four years of
follow-up, it was concluded that a high intake of vitamin C was not associated with a
lower risk of CVD. Similarly, a 20 year study by Gale et ah, found that though vitamin C
levels were associated with risk of death from stroke, it was not associated with a risk of
mortality from heart disease.
3. Antioxidant Effect of Vitamin E
Studies with vitamin E supplementation yielded similar conflicting
results as with vitamin C. Oxidation of LDL varies according to the density of the
species and subspecies involved. Small dense LDL species are more susceptible to
becoming oxidized than large subspecies and thus are more deeply implicated in the
atherosclerotic process (Tribble, Roll, Wood, & Krauss, 1992). This difference was
attributed to the lower antioxidant content of the smaller more dense subspecies of LDL,
specifically of alpha-tocopherol levels (Tribble, Thiel, van den Berg, & Krauss, 1995).
Tribble et al. found that in the presence of vitamin C, alpha-tocopherol depletion slowed
down from small LDL and became more rapid in large LDL species. In a study of 22
healthy male smokers by Neunteufl et al. (1992), supplementation with vitamin E
decreased the extent of transient impairment of endothelial function in heavy smokers by
improving oxidative status. The Nurses’ Health Study found that supplementation with
vitamin E daily was associated with a reduced risk of heart disease among middle-aged
women (Stampfer, et al., 1993). However, the Finnish Alpha Tocopherol Beta Carotene
Cancer Prevention Study concluded that daily supplementation with vitamin E did not
have a significant effect on decreasing the incidence of death due to MI or cardiac arrest
in 27,271 Finnish male smokers (Virtamo, Rapola, & Ripatti, 1998).
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4. Conclusions from Available Data on Vitamin C and E
Despite demonstrating promising results in observational studies for the
primary prevention of CVD, randomized trials with vitamin E and vitamin C have
yielded disappointing results. These conclusions are consistent with the recommendations
of the third U. S. Preventive Services Task Force (USPSTF) not to use supplements of
vitamin A, C, E, beta carotene or antioxidant combinations for the prevention of
cardiovascular disease due to insufficient evidence of their benefit. Though
supplementation studies have yielded conflicting results regarding the role antioxidants
play in preventing heart disease, dietary intake studies have reached different
conclusions. In a prospective study to assess the relationship between plasma ascorbic
acid levels and all-cause mortality, Khaw and colleagues (2001) recruited 19,496 men
and women ranging in age from 45-79 years and followed them for 4 years. Risk of all
cause mortality was found to be lowest among individuals with the highest levels of
plasma ascorbic acid. The researchers concluded that increasing the intake of fresh fruits
and vegetables by one serving may have an impact on disease prevention. A similar study
was conducted in which 34,486 postmenopausal women free of cardiovascular disease
were followed for 7 years to assess the impact of dietary intake of vitamin E on the risk
of mortality due to heart disease Kushi, et al. (1996) concluded that there is an inverse
relationship between eating foods high in vitamin E and risk of death from heart disease.
The antioxidant effect of vitamins E and C as well as beta carotene exerted on the body is
limited by the amount that can be ingested daily. The recommended daily allowance for
vitamin C is set at 60-95 mg per day, and the allowance for vitamin E is set at lOmg per
day (DeBruyne, Pinna, & Whitney, 2008).
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5. Antioxidant Role of Polyphenols
Polyphenols, which are the most abundant form of antioxidants in food,
have received a significant amount of attention from researchers since 1995 (Scalbert, et
al, 2005). The delay of interest in the effects of these compounds can be attributed to their
complexity and variability (Stoclet et ah, 2004). Abundance in food was not the only
aspect of polyphenols that attracted the scientific community however, but also the
quantity that can be safely ingested warranted further investigation for possible disease
prevention. Polyphenol intake can easily reach 1 g daily, which is roughly 10 times the
amount recommended for vitamin C and 100 times greater than the amount
recommended for vitamin E (Scalbert, et al., 2005).
Recent epidemiologic studies supported the role of polyphenols as antioxidants
through the ingestion of different foods such as fruits, vegetables, cocoa and olive oil and
soybeans or beverages such as wine and tea (Stoclet, et al., 2004). Though cocoa and its
many products have received considerable attention in the scientific community recently
for their potential antioxidant effects, there are only a few studies to date that have been
done on humans that examined the antioxidant effect of this substance on oxidative
stress.
6. Antioxidant Effect of Cocoa
A randomized crossover study by Wan and colleagues (2001) was
conducted over a 2 year period to evaluate the effect of cocoa powder and dark chocolate
intake on LDL oxidative susceptibility and total serum antioxidant capacity as well as
urinary prostaglandin concentrations. The study consisted of 23 subjects who were given
two different diets to follow. The first diet was an average American diet that was
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controlled for fiber, caffeine, and theobromine. The second diet was the same as the first,
with the addition of 22g of cocoa powder and 16g of dark chocolate. The results of the
study indicated a slight reduction in LDL oxidation susceptibility when participants
ingested cocoa powder and dark chocolate. Another randomized study examining the
effect of dark chocolate on vascular and platelet function in heart transplant patients
found that eating 40g of dark chocolate not only improved coronary vascular and platelet
function, but also caused a reduction of serum oxidative stress (Flammer et ah, 2007).
7. Antioxidant Effect of Grapes and Red Wine
The healthful effects of the Mediterranean diet on the risk of
cardiovascular disease have been attributed to the abundance of olive oil and red wine in
the diet (Zem & Fernandez, 2005). Red wine intake also was said to explain the “French
Paradox” in which the French show low heart disease rates despite a diet high in
saturated fat (Zem & Fernandez, 2005). This effect was found to be mainly due to the
high flavonoid and polyphenol content of grapes (O’Bryne, Devaraj, Gmndy, & Jialal,
2002). Concord grape juice and red wine were shown to have similar polyphenol content
and thus they both produced similar effects in decreasing oxidative stress, which in turn
decreased the risk of developing CVD (Durak, et al., 1999). Grape juice would be the
more appealing beverage to promote for its antioxidant effect since it does not have the
addiction factor associated with alcohol. A study by O’Bryne et al., (2002) compared the
effect of supplementation with 400 IU alpha-tocopherol with ingestion of Concord grape
juice and found both substances increased serum antioxidant capacity and protected
against LDL oxidation. Concord grape juice was found also to decrease plasma protein
oxidation, which led the investigators to conclude that it is a more potent antioxidant than
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alpha-tocopherol. Polyphenols from red wine have also been shown to increase
antioxidant capacity through rapid absorption (Garcia-Alonso, et ah, 2008). In another
study by Chou, et ah, (2001), purple grape juice was given to participants alone or in
combination with vitamin E to assess endothelial function as well as antioxidant effects.
The results showed an improvement in endothelial health, as well as an increase in
antioxidant levels without affecting lipid or glucose metabolism.
8. Antioxidant Effect of Olive Oil
Olive oil is another substance that is high in polyphenols and has been
shown to affect oxidative stress levels. In a randomized trial to assess olive oil’s role as
an antioxidant, researchers randomly assigned participants to three sequences of daily
intake of the oil 3 times a day. The sequences referred to the phenolic content of the oil
and were as follows: sequence 1: high medium and low polyphenol olive oil; sequence 2:
medium, low and high polyphenol olive oil; and sequence 3: low, high and medium
polyphenol olive oil. Oxidative stress, measured as oxidized LDL, was found to have an
inverse linear relationship with polyphenolic content (Covas et ah, 2006). Another study
to determine the effects polyphenol-rich olive oil has on oxidative stress yielded similar
results as the earlier study, with an additional increase in high density lipoprotein (HDL)
levels than other types of olive oil (Marrugat et al. 2004).
9. Antioxidant Effect of Tea and Soy
Tea is the most consumed beverage in the world and consists of more than
400 bioactive chemicals (Yung, et ah, 2008). Recently, tea had been linked to CVD
protection due to its high antioxidant content (Yung et al., 2008). Japanese green tea, for
example, was shown to decrease plasma oxidized LDL levels in 40 healthy adult
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volunteers, ultimately decreasing the risk associated with heart disease (Inami et ah,
2007). Ingestion of green tea by 12 healthy male volunteers for 4 weeks caused a
significant decrease in oxidized LDL levels, suggesting a potential benefit of influencing
the development and progression of atherosclerosis (Sung, et ah, 2005). Black tea has
also been linked to coronary artery disease as demonstrated by a metanalysis of available
data between 1990 and 2004 that found that consumption of three or more cups of black
tea per day decreased CVD risk through tea’s polyphenol action (Gardner, Ruxton, &
Leeds, 2007). Soy has also been shown to reduce oxidative stress, as well as the risk of
cardiovascular disease, though it has not been studied as extensively as other polyphenolrich products (Mota et ah, 2007). Several studies have concluded that more studies on
the antioxidant effect of soy are needed to make more concrete recommendations (Clair
& Anthony, 2005).
C. Anti-inflammatory Effect of Polyphenols
1. Role ofInflammation in Cardiovascular Disease
The antioxidant effect of polyphenols is not the only factor that affects the
development of atherosclerosis. Inflammation is also a major part of the atherosclerotic
process and has been shown to lead to more complications such as MI and stroke
(Paoletti, Gotto, & Hajjar, 2004). Oxidized LDL elicits an inflammatory response that
leads to the formation of fatty streaks on the arterial wall (Berliner et ah, 1995). The
inflammatory response involves the release of a group of molecules, referred to as
cytokines, which in turn affect the levels of different biological markers in the body, such
as C- reactive protein (CRP; Berliner, et ah, 1995). Of all the inflammatory biomarkers,
CRP is the most studied and has been linked to cardiovascular disease in numerous
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studies, even though the exact mechanism of action was not clear (Ridker & Blake, 2003;
Ridker, 2007).
2. CRP’s Role in Cardiovascular Disease
Recent studies have demonstrated the importance of the inflammatory
process in predicting cardiovascular events and how CRP can be used as a tool to assess
the extent of this inflammation, which would improve outcome and prevent disease. A
study by Ridker, Cushman, stampfer, Tracy and Hennekens (1997) sought to measure
inflammation and its effect on the occurrence of a cardiac event. The study consisted of
543 otherwise healthy men from the Physician’s Health Study, who eventually developed
heart disease, and compared them to an equal number of participants who had never
developed the disease. The participants were randomly assigned to either an aspirin
regiment or a placebo one at the beginning of the trial and were followed for 8 years.
Assessment of inflammation was done by measuring plasma CRP levels. Among the
participants who eventually developed heart disease, CRP levels were elevated at
baseline with those in the highest quartile having a threefold increase in risk. Aspirin
reduced the risk of an MI in those with the highest levels of CRP, which the researchers
concluded could have clinical implications in preventing heart disease. In another study
conducted on a different participant sample of almost 15,000 men from the Physician’s
Health Study found that CRP measurements, along with measurements of total
cholesterol and HDL, were also significant in predicting a cardiovascular event (Ridker,
Glynn, & Hennekens, 1998).
The ability of C-reactive protein to predict the risk of a cardiovascular event goes
beyond circulating levels in the blood. Examination of 17 patients who died of an MI
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event found CRP deposits in the infarcted tissue along with fragments from the pathway
of complement (Lagrand et ah, 1997). This conclusion was supported by another study
in which CRP and complement were found to be strongly associated with post infarct
death and were identified as targets of heart disease therapy (Griselli et ah, 1999).
Furthermore, C-reactive protein was also found to be elevated in patients with unstable
angina when compared to those with stable angina (Berk, Weintraub, & Alexander,
1990). The researchers in the study concluded that high levels of CRP in unstable angina
may be linked to future cardiac events (Berk, et ah, 1990). Levels of CRP in unstable
angina were not found to increase by transient ischemic events (Berk, et ah, 1990).
Scientific research was also able to demonstrate the usefulness of CRP levels in
not only predicting future cardiac events, but also distinguishing between patients with
unstable angina and those with long standing angina who have never been stable. Blood
levels of several substances, namely lipoprotein(a), homocysteine, tissue plasminogen
activator, plasminogen activator inhibitor-1, CRP, fibrinogen, and von Willebrand factor
were compared to determine their ability to distinguish between unstable angina (multiple
acute ischemic events) and long standing stable angina (Bogaty et ah, 2001). Fifty
participants were grouped into one of three condition groups: previous repeated coronary
events, stable angina with no coronary events, or control (without any evidence of heart
disease; Bogaty, et ah, 2001). Only CRP was found to distinguish between those who
have unstable angina and those with stable angina. Another study examined the efficacy
of two acute phase reactants, CRP and serum amyloid A protein (SAA) in predicting
coronary events in patients with stable and unstable angina (Haverkate, Thompson, Pyke,
Gallimore, & Pepys, 1997). The results demonstrated that elevated CRP levels were
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better predictors of coronary events in stable as well as unstable angina, while SAA was
not (Haverkate et al., 1997).
3. Anti-inflammatory Effect of Tea
Although sparse, evidence that polyphenols affect inflammation levels in
the body does exist. Tea, a rich source of pranthocyanidin polyphenols, was studied to
determine its effect on inflammation. On a molecular level, tea was found to decrease
inflammation by inhibiting the release of cyclooxygenase-2 (COX-2) and nitric oxide
(NO), which are both important biological mediators implicated in the inflammatory
pathway ( Hou, et al., 2007). Tea was also found to exhibit anti-inflammatory effects by
decreasing the production of IL-6 cytokines that signal the release of inflammatory
markers, such as CRP (Tipoe, Leung, Hung, & Fung, 2007).
4. Anti-inflammatory Effect of Olive Oil
Olive oil also was found to have anti-inflammatory effects in
cardiovascular disease, which was attributed to its high polyphenol content (Patrick &
Uzick, 2001). A study that compared 50ml of two kinds of olive oil (refined and virgin)
on inflammatory markers in patients with stable heart disease found that consumption of
virgin olive oil decreased CRP, as well as its precursor IL-6, in patients with stable
coronary heart disease (Fito et al., 2008).
5. Anti-inflammatory Effect of Cherries
Additionally, dietary intake of cherries has been shown to affect levels of
inflammatory markers in the body. Eighteen healthy men and women added Bing
cherries to their diets for 28 days. Blood samples were taken at baseline, after 14 days
and again at 28 days. Results showed a decrease in both CRP and NO levels 28 days post
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study (Kelley, Rasooly, Jacob, Kader, & Mackey, 2006). The common factor between
tea, olive oil and cherries is the presence of polyphenol compounds. Although the
mechanism of action of the anti-inflammatory effect in this substance is not well
understood, the potential benefit warrants further investigation.
D. Figs and Polyphenols
Figs are one of the first fruits to be cultivated around the world. In addition to
their sweet taste and high fiber content, figs have a very high level of polyphenols
compared with other fruits and vegetables. According to the California Fig Advisory
Board, a study conducted by the University of Scranton, Pensylvania, found that the
polyphenol content of figs was more than quadruple the amount found in other fruits
(California Fig Advisory Board, 2008). Comparison of the polyphenolic content of six
different varieties of figs showed darker varieties to have higher antioxidant levels than
their lighter counterparts (Solomon et ah, 2006). Most of the polyphenols in the fruit
were found to be concentrated in its skin, which attributed to its higher antioxidant levels.
The Mission fig variety was found to have the highest polyphenolic levels of flavonoids
as well as exhibiting the highest antioxidant capacity (Solomon, et ah, 2006). Due to
their polyphenolic density and superior quality, figs are qualified candidates for further
study.
There are two proposed effects that polyphenols can potentially exert on the body
to lower the risk of CVD. One is through an anti-inflammatory pathway and the other is
through an antioxidant effect. The antioxidant effect of polyphenols has been well
explored and documented, while the anti-inflammatory pathway has been less
investigated. California Mission figs are rich in polyphenols, but the extent of an anti27

oxidant or anti-inflammatory effect has not been studied. The purpose of this study is to
determine the existence and extent of such an effect.
E. Conclusions
Polyphenols have been shown to affect cardiovascular disease through an
antioxidant and anti-inflammatory pathway. These two pathways are not completely
independent of each other since they involve many of the same foods. Studies involving
the antioxidant pathway demonstrated a polyphenolic effect on oxidative stress through a
decrease in levels of oxidized LDL, which in turn decreased the formation of fatty streaks
that lead to atherosclerosis. The anti-inflammatory pathway was less clear, but some
evidence showed a possible mechanism of action by decreasing CRP levels. Even though
several pharmacological therapies affect CRP levels and thus lower inflammation in the
body, the benefit does not come without side effects. Natural foods, on the other hand, do
not have side effects and are less expensive to acquire than medications.
The human and material loss associated with CVD warrants the further
investigation of the implication of polyphenols in the treatment of CVD. Figs have not
been studied extensively or exclusively, but according to Vinson et ah, (2005) affect
inflammatory levels in the body, as well as exert an antioxidant effect. According to the
Fig Advisory Board, figs are well known for their nutritional benefit all over the world
and can be grown in a cost effective manner in most regions. Demonstrating their effect
in combating heart disease would be a great tool in aiding the fight against this disease.
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CHAPTER 3
METHODS

A. Overview
Analyses were performed on data collected from participants who took part in a
randomized crossover study to assess the effect of California Mission fig consumption on
CRP and antioxidant levels in the body. Below are the details of the study followed by
the specifics of the analyses.
B. Study Design
The study was designed to be a 12 week randomized crossover study with an
intervention and a control phase, each lasting 5 weeks (Table 1). The screening period
lasted 2 weeks, after which 102 adult men and women were randomly assigned to either
the intervention (eating figs) or control study phase (not eating figs) for the first 5 weeks
of the trial and then were crossed over into the other phase for the second 5 weeks.
During the intervention phase participants were asked to incorporate a prepackaged, pre
weighed 40 gram serving of California Mission figs (3-5 figs) at each meal for a total of
three meals a day in their daily diet. Participants consumed their normal everyday diet
while participating in the study with the exception of incorporating figs as part of their
meals during the intervention phase and abstaining from ingesting figs or prunes during
the control phase. Each study participant received a $25 gift card upon completion of the
study.
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Table 1. Study Design
Weeks
Groups

0 and 2

2 to 6

6 and 7

7 to 11

11 and 12

1

Screening

Reg. Diet

Blood Draw/
Crossver
Week

Reg. Diet w/
Figs

Blood Draw/
End of Study

2

Screening

Reg. Diet
w/ Figs

Blood Draw/
Crossover
Week

Reg. Diet

BloodDraw/
End of Study

The Gantt chart and the budget for the study are shown in Appendices C and D.
C. Study Participants
Approximately 141 potential subjects were recruited and screened. Eligible
participants were men and women aged 30 to 75 years with LDL cholesterol
concentrations in the above optimal (100-129 mg/dL) or borderline (130-159 mg/dL)
level. Individuals with LDL levels of 160-189 mg/dL were only allowed to participate
with the permission of a physician. Inclusion of participants with elevated levels of LDL
was done purposefully to ensure that CRP levels would be elevated in the study
population. Additional inclusion criteria were a body mass index (BMI) of 18.5-35
kg/m2, no cigarette smoking within the past year, and a written informed consent.
Exclusion criteria were any secondary cause of hyperlipidemia (kidney or liver disease,
untreated hypothyroidism); current or previous (within the past 2 months) use of any
lipid-lowering drug; Type 1 diabetes or uncontrolled Type 2 diabetes (HbAlc > 7%);
triacylglycerol concentrations >300 mg/dL; current or previous (within the past 3
months) treatment with estrogen or steroid therapy; stated dislike of figs; use of certain
dietary supplements, e.g. Metamucil, sterol/stanol margarine and others that may
influence lipid concentrations; chronic disease that may affect concentrations of lipids or
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markers of inflammation (e.g cancer other than skin cancer within the last 5 years,
chronic rheumatological disease, chronic severe depression), and any condition deemed
by the study investigators to limit compliance with the protocol (e.g. drug abuse).
D. Recruitment
Participants were recruited from churches and businesses in communities in and
around San Bernardino, California. Presentations and flyers about the California Mission
fig study were presented at churches and business establishments as well as at the
Drayson Center exercise facility at Loma Linda University. Potential subjects were
recruited by flyers approved by the university’s Institutional Review Board. Registration
sheets were left at different recruiting sites for individuals and were the basis for later
communications by the researchers. Upon arrival at the scheduled screening
appointments all study procedures were explained in detail and a signed informed consent
form was obtained from each eligible participant. Only subjects who signed the consent
form were allowed to take part in the study.
E. Procedures
The week by week procedures are given in Table 2.

31

Table 2. Week by Week Procedures
Weeks
Week 0 to 2
Screening
(fasting, if not
fasting, one extra
visit will be
required within
this period)

Procedures
Initial visit: Potential subjects were individually given a detailed
explanation about the purpose of the study and the procedures
they would follow during the course of the 12-week study as
described above.
Subjects were informed that the only change required in their
regular diet was the inclusion of 3-5 dried mission figs (serving
size of 40 grams) eaten at each meal everyday for a period of 5
weeks during the intervention phase of the trial.
Consumption of figs beyond this limit or prunes was not allowed
throughout the study.
Informed, written consent was obtained.
A complete health questionnaire was completed during the
screening period (Appendix D). Subsequent brief health
questionnaires were completed at different intervals throughout
the study (appendix E).
Baseline blood samples were drawn after a 12 hour fasting period
at the screening visit, or within 10 days of enrolling in the study.
Vital signs and anthropometries were measured and recorded.
Potential participants who met the study criteria in regard to the
fasting serum concentrations were contacted by telephone and
given an appointment for the week 2 randomization visits which
were scheduled within 2 weeks of the screening visit.

Week 2
Randomization
(nonfasting)

Procedure for randomization: A random numbers table was
used to generate a list of partcipants. Even numbers designated
randomization to the intervention phase followed by the control
phase. Odd numbers designated randomization to the control
phase followed by the intervention phase. Numbers and their
assigned status were written on slips of paper and placed in
consecutively numbered opaque envelopes. Subjects were
consecutively assigned a randomization number corresponding to
the number on the envelope randomly pulled. After assignment of
the number, the envelope was opened and the group assignment
noted and the subject informed.
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Table 2 (continued). Week by Week Procedures
Week 2
Randomization
(nonfasting)
(Continued)

Subjects randomized to the fig study phase (intervention) first
received enough prepackaged fig portions for 3 weeks of
consumption (1 extra week in case the follow-up visit is delayed)
while those in the control phase were advised to continue their
regular diet and not to eat any figs or prunes for 5 weeks.

Week 2
Randomization
(nonfasting)

Subjects concerned about weight gain were permitted to substitute
the figs for their usual desserts or sweet snacks. If the fig portions
were forgotten (e.g. not taken to work) they were consumed at a
later time in the day with meals or as a snack. Daily compliance
with the assigned portions of figs was recorded on a compliance
form provided (see Appendix F).
Vital signs and anthropometries were measured and recorded.
The study procedures were reiterated and subjects were asked to
complete a short health questionnaire (appendix E), to check
whether any changes occurred in their health status or use of
medications since the screening visit.

Week 4
(Follow-up
visit/fig pickup
for intervention
group nonfasting)

Vital signs and anthropometries were measured and recorded.
Participants in the intervention phase picked up figs for the
remaining 3 weeks plus an extra week’s supply.
A reminder to follow the study protocol was given to all study
participants. Also participants were encouraged to ask any
questions they had regarding their diet.
Compliance sheets were gathered and new ones were provided.
Participants who were consuming their usual diet were reminded
not to consume any figs or prunes for the remainder of the study
phase.
Subjects were interviewed in person or by phone to obtain a 24
hour dietary recall. A telephone interview to obtain a 24-hour
dietary recall was performed on a randomly selected day between
weeks 4 and 6.
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Table 2 (continued). Week by Week Procedures
Week 6 Follow
up visit
(fasting)

Vital signs and anthropometries were measured and recorded.
All the participants in the study had blood drawn after a 12 hour
fast.
Compliance sheets were gathered from participants consuming figs
and new ones provided.

Week?
Crossover visit
(fasting)

Vital signs and anthropometries were measured and recorded.
All participants in the study had blood drawn after a 12 hour fast.
Compliance sheets will be gathered from participants consuming
figs.
Participants crossed over into opposite phase: Those who were not
eating figs began consuming 40g prepackaged figs at each meal
three times daily and those who had stopped ingesting the figs and
resumed their regular diet.
Compliance sheets were given to the new intervention group along
with a 3 week supply of figs (1 extra week in case of delay of
follow-up appointment)

Week?
Crossover visit
(fasting)

Instructions were given to participants not to consume any other
than the prepackaged figs or prunes during the subsequent five
weeks. Those who had just completed the intervention phase were
instructed to abstain from eating any figs or prunes with their
meals.
Those concerned about weight gain were advised to alter their
daily intake to account for the 330 kcalories from figs.
All subjects completed a brief health questionnaire that included a
question that assessed their satisfaction with eating figs (Appendix
E)
A telephone interview to obtain a 24-hour dietary recall was
performed on a day randomly selected day between weeks 7 and 9.

Week 9
(Follow-up
visit/fig pick-up
for the
intervention
group nonfasting)

Vital signs and anthropometries were measured and recorded.
Participants who were in the intervention phase picked up figs for
the remaining 3 weeks plus an extra week’s supply.
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Table 2 (continued). Week by Week Procedures
Week 9
(Follow-up
visit/fig pick-up
for the
intervention
group nonfasting)
(Continued)

Week 11
Follow-up visit
(fasting)

A reminder to follow the study protocol was given to all study
participants. Also participants were encouraged to ask any
questions they had regarding their diet.
Compliance sheets were gathered and new ones provided. Those
consuming usual diet were reminded not to consume any figs or
prunes for the remainder of the study phase.
Subjects were interviewed in person or by phone to obtain a 24
hour dietary recall. A telephone interview to obtain a 24-hour
dietary recall was performed on a randomly selected day between
weeks 4 and 6.
Vital signs and anthropometries were measured and recorded.
All study participants had blood drawn after a 12 hour fast.
Compliance sheets were gathered from participants consuming figs
and new ones provided.

Week 12
Follow-up visit
(fasting)

Vital signs and anthropometries were measured and recorded.
All the participants in the study had blood drawn after a 12 hour
fast.
Compliance sheets were gathered from participants consuming
figs.
All subjects completed a brief health questionnaire that included a
question that assessed satisfaction with eating figs (Appendix E)
A thank you letter was given to each participant who completed
the 12 week fig research study along with a $25 gift card.
Current addresses were confirmed/obtained for later mailings of
final blood results.

F. Procedures for Blood Draws
At each visit involving blood draws (screening, week 6, week 7, week 11, and
week 12), subjects were asked to fast overnight. Water and standard allowed medication
were to be taken on the morning prior to the visit. Blood samples were drawn between
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7:00 to 10:00 a.m. At screening, one 10 ml red top tube was drawn and centrifuged.
Experienced certified venipuncturists were hired to perform the blood draws and samples
were sent to the Loma Linda University Medical Center Clinical Laboratory for analysis
of total cholesterol, LDL cholesterol, HDL cholesterol and triacylglycerol levels as well
as ALT, creatinine and glucose. At follow-up visits 6, 7, 11 and 12, one red top tube of
10 ml and one 4 ml green top tube for plasma was drawn. The blood was allowed to cool
for about 10-15 minutes at room temperature before being put on ice. Samples were
placed in a cooler and transported to Nichol Hall Room 1112 where they were separated
in a refrigerated centrifuge at 1800 x g and 4 degrees centigrade. Serum/plasma was
aliquoted into vials and kept in a -70 degree Fahrenheit freezer in Nichol Hall Room
1112A, the Nutrition Department laboratory.
G. Measurement of Blood Pressure and Pulse
Blood pressure and pulse measurements were taken before blood tests were
completed and after participant had rested for at least 5 minutes. Blood pressure
measurement procedure is indicated in Table 3.
Table 3. Blood Pressure and Pulse Procedure
Step
1
2
3
4

5
6

Procedure
Subject was seated with back supported and arm bare and
supported.
Subject refrained from ingesting caffeine for 12 hours before
measurement was taken.
Measurement began after at least 5 minutes of rest.
Appropriate cuff size and calibrated equipment was used.
Two readings were obtained for each participant and averaged.
Pulse was measured for 60 seconds before blood pressure
measurement.
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H. Measurement and Justification of Anthropometries
Though the only dietary change that participants experienced with the study was
the inclusion of figs for 5 weeks, it was important to monitor weight change throughout
the process. Figs have a high content of fiber which may have lead some of them to feel
full faster and thus eat less overall. This may have led to some weight loss over time and
may have provided a future venue for research.
1. Height and Weight
Height was measured (without shoes) using a standard and calibrated wall
stadiometer only at the screening visit. Subjects were weighed using a standard scale at
screening and weeks 6, 7, 11 and 12 of the study period. This scale was designed for
patients up to 600 pounds and was last calibrated in November 2007.
2. Weigh-in Procedure
The weigh-in procedure used is indicated in Table 4 below.
Table 4. Weigh-in Procedure
Step
1
2
3
4
5

Procedure
Remove shoes
Remove jacket and other outer garments
Empty pockets
Stand on scale and wait for Assistant 2 to record measurement
Record results in the chart

3. Waist Circumference
Waist circumference was measured to the nearest 0.1 cm at the narrowest
level over light clothing, with the use of an unstretched tape measure and without any
pressure to the body surface. Waist was measured at screening and at weeks 7 and 12.
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I. Tracking Procedures
On the evening before appointments, participants were called as a reminder and
for fasting visits, to be fasting on the morning of the visit. E-mail was used instead of a
phone call when appropriate and when requested by participants. Participants who
missed their scheduled appointments were contacted for a new appointment if they
wished to continue in the study.
J. Dietary Assessment and Tracking Procedures
Dietary assessment was needed to monitor changes in the diet other than those
attributed to an increased consumption of figs during the intervention phase compared to
the control phase. This was documented by two phone interviews and one in-person
interview to obtain dietary information (24 hour diet recall as described in Appendix H)
on all randomized participants in each study phase for a total of 6 recalls. The phone
interview was completed on a random day between weeks 2 and 4, weeks 4 and 6, weeks
7 and 9, and weeks 9 and 11. The day was chosen by pulling a weekday or weekend day
from a box containing folded papers labeled Sunday through Friday, after which they
were returned to the box. If the interview was not possible on the drawn day, it was
conducted as soon as possible thereafter. The in-person interviews were completed on the
week 4 and week 9 visits.
The Nutrition Data System for Research (NDSR), which is maintained by the
Nutrition Coordinating Center at the University of Minnesota, was the software used to
acquire the 24 hour dietary recall. The recall was performed by registered dietitians. A
list indicating portions of sweet snacks and desserts that could be substituted by figs is
provided in Appendix H.
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K. Nutritional Analysis of California Mission Figs
California Mission figs were obtained from the California Fig Board. An analysis
was performed on California Mission figs to determine the amount of soluble and total
fiber present in a serving (40 grams) of figs. The California Fig Advisory Board has the
following data showing the B-glucan content of mission figs (Table 5).
Table 5. Caloric and Nutrient Content in a 40 Gram Serving of California Mission Figs
Nutrition Facts
Serving Size
Kcalories
Total Fat
Saturated Fat
Trans Fat
Cholesterol
Sodium
Total carbohydrate
Dietary Fiber
Sugars
Protein
Vitamin A
Calcium
Vitamin C
Iron

lA cup (40 grams)
110
0g (0%)
0g (0%)
0g(0)
0 mg (0%)
5 mg (0%)
26 g (9%)
5 g (20%)
20 g (10%)
lg(l%)
<2%
6%
<2%

6%

L. Data Analysis of CRP and Antioxidant Levels
Data entry and analyses was conducted by the doctoral student (RA). All data
was entered into the SPSS version 16 database and a 10% random sample was re-entered
to check for accuracy. Variables were checked for skewedness and log transformation
was done on CRP, antioxidant capacity levels and dietary recall. However, nontransformed data were presented as part of results. Antioxidant, CRP and dietary recall
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data were analyzed using a paired t-test while other variables were compared using a
student’s t-test. Descriptive statistics were expressed as means and standard deviations
for normally distributed variables, and medians and percentiles for skewed variables.
1. CRP Analysis
Frozen samples for the analysis of CRP were sent in a single group at the
end of the trial for analysis at the Research Laboratory, University of California at Davis.
The method employed was a high-sensitivity CRP analysis test. Testing for CRP at
University California at Davis utilized a PolyChem analyzer from PolyMedCo.
Coefficient of variability (CV) for runs done on three sets of controls yielded 5.72%.
2. Antioxidant Analysis
Samples were analyzed for antioxidant capacity in the Nutrition laboratory
at Loma Linda University. The two tests employed were the Ferric Reducing
Antioxidant Power (FRAP) and the Total Antioxidant Capacity (ABTS) tests are
indicated in Table 6 (refer to Appendix I and J for complete protocols).
Table 6. Testing Protocol for Ferric Reducing Antioxidant Power (FRAP) and the Total
Antioxidant Capacity (ABTS) Tests
Components of FRAP Test
A ratio of 10:1:1 of buffer (a mixture of sodium acetate and
FRAP reagents
glacial acetic acid and water): Tripyridyltriazine (TPTZ):
FeC13.
A 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
Trolox Stock Standard
Plasma dilution
5:1 ration of plasma to water.
Reagent was mixed with plasma in a 96-well assay plate and
Reagent
analyzed in the Synergy apparatus.
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Table 6 (Continued). Ferric Reducing Antioxidant Power (FRAP) and the Total
Antioxidant Capacity (ABTS) Tests.
Components of ABTS Test
A mixture of ABTS and potassium persulfate in phosphate
ABTS solution
buffered saline)
A 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
Trolox Stock Standard
Analyses

Solutions were combined and placed in a spectrophotometer
in a timed process for analysis

Baseline data for gender distribution mean values of BMI, waist circumference,
blood pressure, pulse, and lipid concentrations at screening for participants were analyzed
to ensure success of randomization. Participants’ weights were analyzed for the two
study phases and if they were found to be statistically significantly different, data would
have been analyzed controlling for weight.
Compliance with fig consumption was estimated from the compliance sheets and
subjects who consumed <75% of the assigned figs would have been designated as noncompliers, and analysis would be performed with and without these participants. Creactive protein and antioxidant levels at weeks 6 and 7 and at weeks 11 and 12 were
averaged to minimize day to day variability and analyzed.
Dietary data was analyzed for difference in calories, macronutrients and minerals
between participants in the two study phases. Mean blood pressure, pulse and body
weight measurements at the end of the intervention and control phases were analyzed and
presented. All results were considered significant for a two-tailed P values <0.05.
Statistical analyses were performed using SPSS for WINDOWS (SPSS, Chicago, IL).
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M. Power Analysis
Power analysis was based on calculations done for a concurrent study that sought
to determine if fig consumption affected lipid levels in the body. Since the population
parameter was not known then s\ and S2 was used to calculate a weighted average that
estimates 5
2

Ch,-1 Qf □ □22“ 1 Q2
n\ +n2~ 2

The sample size was given a mean expected 5-6% reduction in LDL cholesterol
with an SD of the change of 5-6%. For a mean difference of 5 and SD of 8 using the
equation shown results in a sample size of (1.96+0.84)A2*2*64/25=40.1~41 giving a total
sample size of 82. From SPSS output the total sample size requirement for the study was
84 for a power of 80%. If we allow for a dropout rate of up to 20%, the final number for
the study will be 84 + 16 = 100 participants
N. Strengths and Limitations
The main strength of the study was the randomized, crossover design with
subjects serving as their own controls and the adequate, calculated power. The theoretical
underpinnings were excellent. The intervention was simple to administer to participants
since the figs were prepackaged.
There were also several limitations. Subjects were free living and there was no
way to control other food intake. Subjects concerned about weight gain may have
substituted figs for desserts and sweet snacks as advised, which may have lowered lipid
concentrations due to the substitution. The dietary recall analysis will result in data
showing whether the composition of the diet changed between the two periods other than
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in regard to fig intake. Compliance may have been affected since participants had to eat
figs continuously, though this is unlikely since the intervention period was only 5 weeks.
Since antioxidants are at the highest levels immediately after a meal, frozen
samples taken after a 12 hour fast might yield compromised values. C-reactive protein
levels also vary greatly within individual measurements and are affected by many factors
including medications, but since each participant will act as their own control, this effect
should be minimized.
O. Research Ethics
In the parent study, respect and confidentiality was maintained by storing patient
information in a locked room and not allowing access to anyone other than the research
team. All blood samples were labeled with the participants' randomized number code,
minimizing any issues with confidentiality. All data was stored separately from
identifying information. In addition, computers as well as data files were password
protected to further protect against any breach of confidentiality. Only the primary
investigator had linking access. All data analyses were conducted on de-identifled data.
Only trained IRB certified health professionals were in contact with participants.
Participants were provided with an informed consent document explaining all the
test procedures and possible side effects or risks, if applicable, to maximize benefits and
minimize possible harms. Harms in this study were limited to hematoma, lightheadedness
or other complications of venipuncture.
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Abstract
Background and Aims: Polyphenols exert both anti-inflammatory and antioxidant
effects. We investigated the effect of consuming polyphenol-rich figs on high sensitivity
C-reactive protein (CRP) and antioxidant levels in hyperlipidemic subjects. Methods and
Results: Men and women with elevated LDL cholesterol levels (100-189 mg/dL) were
eligible. The study had a randomized crossover design, where 141 potential participants
were screened and 102 randomized to either consume 120 g/day of California figs
(intervention phase) or no figs (control phase) for five weeks. Mean CRP values did not
differ significantly in the intervention phase when compared to the control phase (median
[interquartile range] 1[0.5, 2.1] mg/L versus 1 [0.6, 2.1]; P=0.31). Ferric reducing
antioxidant power (FRAP) test results did not differ between study phases either (0.1+
0.1 mmol versus 0.1+ 0.1 mmol; P = 0.96). Total antioxidant capacity (ABTS) test
concentrations also did not differ during the two phases (0.2+ 0.04 mmol versus 0.2+
0.04 mmol; P = 0.97). Furthermore, analysis of dietary intake revealed that participants
consumed approximately 187 calories more in the intervention phase (PO.OOOl), while
consuming 4% less calories from fat (PO.OOOl). Conclusions: For men and women
with elevated cholesterol levels, fig consumption did not lower CRP or affect antioxidant
levels.

Keywords: Cardiovascular disease, C-reactive protein, Antioxidants
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Introduction
Cardiovascular disease (CVD) has been the leading cause of death in both women
and men since the year 1900, with the exception of the 1918 influenza epidemic
(American Heart Association [AHA], 2007). Cardiovascular disease is an international
problem that, in 2001, was implicated in almost one third of all global deaths (AHA,
2009). Even though cardiovascular disease mortality rates have been decreasing since
2003, largely due to advances made in medicinal therapies (Capewell, Beaglehole,
Seddon, & McMurray, 2000), the progress achieved is diminished by the fact that the
underlying risk factors for CVD are still on the rise (AHA, 2007).
Risk factors for CVD are mostly lifestyle related, which can drastically alter risk
when modified, and include high blood pressure, high cholesterol, diabetes, smoking,
physical inactivity, and obesity. These risk factors, although diverse, have a common
effect on the development of atherosclerosis, a chronic inflammatory disease
characterized by plaque formation in medium sized arteries that can be present for years
before it manifests itself in a variety of CVD forms, such as myocardial infarction (MI) or
even sudden cardiac death (Ross, 1999).
Several studies have examined the effect of polyphenols on the incidence of
cardiovascular disease through an antioxidant pathway. Oxidative stress has been shown
to play a critical role in causing endothelial dysfunction, which leads to atherosclerosis
(Davignon & Ganz, 2004). According to Steinberg, Parthasarathy, Carew, Khoo and
Witztum (1989), high plasma levels of low density lipoproteins (LDL) accumulate into
the arterial intima, which are then oxidized, forming fatty streaks that result in endothelial
injury.
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Polyphenols are natural compounds abundant in plant foods that can be ingested
in greater amounts than other substances with similar effects, such as vitamins C and E.
Recent epidemiologic studies supported the role of polyphenols as antioxidants through
the ingestion of different foods, such as fruits, vegetables, cocoa, olive oil and soybeans
or beverages, including wine and tea (Stoclet, et ah, 2004). There are only a few studies
to date that have utilized human subjects to examine the antioxidant effect of polyphenols
on oxidative stress.
The antioxidant effect of polyphenols is not the only factor that affects the
development of atherosclerosis. Inflammation is also a major part of the atherosclerotic
process and has been shown to lead to more complications, such as MI and stroke
(Paoletti, Gotto, & Hajjar, 2004). Oxidized LDL elicits an inflammatory response that
leads to the formation of fatty streaks on the arterial wall (Berliner, et al., 1995). The
inflammatory response involves the release of a group of molecules referred to as
cytokines, which in turn affect the levels of different biological markers in the body, such
as C-reactive protein (CRP; Berliner, et al., 1995). Of all the inflammatory biomarkers,
CRP is the most studied and has been linked to cardiovascular disease in numerous
studies, though the exact mechanism of action is not clear (Blake & Ridker, 2003; Ridker
2007).

In a previous study, researchers sought to determine the amount and quality of
phenol antioxidants in dried fruit and compare them to fresh fruits (Vinson, Zubik, Bose,
Samman, & Proch, 2005). In examining the concentrated form of the fruit, the
researchers sought to investigate how the quality, as well as the quantity, of phenol
antioxidants would differ between dried and fresh apricots, cranberries, dates, figs, raisins
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and prunes (Vinson et al., 2005). The analysis of the data showed that dates had the
highest concentration of polyphenols, while dried figs and plums had the best nutrient
score among the dried fruit, as well as the most superior quality of antioxidants (Vinson
et al, 2005). In conclusion, figs, with their higher quality phenols, are the most suitable
fruit to use for further study to examine the effect of polyphenols on antioxidant and
inflammatory levels in the human body.
Methods
The study was a 12 week randomized crossover study with an intervention and a
control phase, each lasting 5 weeks. The screening period lasted 2 weeks, after which
102 eligible adult men and women were randomly assigned to either the intervention or
control study phase. During the intervention phase participants were asked to incorporate
a prepackaged, pre-weighed 40 gram serving of California mission figs (3-5 figs) at each
meal for a total of 120 grams a day in their regular diet. Participants consumed their
normal everyday diet while participating in the study, with the exception of incorporating
figs as part of their meals during the intervention phase and abstaining from ingesting figs
or prunes during the control phase. In addition, each study participant received a $25 gift
card upon the completion of the study.
Approximately 141 potential participants were recruited and screened. Eligible
participants included men and women aged 30 to 75 years with low density lipoprotein
(LDL) cholesterol concentrations in the above optimal (100-129 mg/dL) or borderline
(130-159 mg/dL) level. Individuals with LDL levels of 160-189 mg/dL were only
allowed to participate with a physician’s permission. The recruitment of individuals with
elevated LDL levels was intentional since such a condition affects CRT levels, thus
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allowing for the detection of change due to the ingestion of figs. Additional inclusion
criteria were a body mass index (BMI) of 18.5-35 kg/m2, no cigarette smoking within the
past year, and written informed consent. Exclusion criteria were any secondary cause of
hyperlipidemia (kidney or liver disease, untreated hypothyroidism); current or previous
(within the past 2 months) use of any lipid-lowering drug; Type 1 diabetes or
uncontrolled Type 2 diabetes (HbAlc > 7%); triacylglycerol concentrations >300 mg/dL,
current or previous (within the past 3 months); treatment with estrogen or steroid therapy;
stated dislike of figs; use of certain dietary supplements, e.g. Metamucil, sterol/stanol
margarine and others that may influence lipid concentrations; chronic disease that may
affect concentrations of lipids or markers of inflammation (e.g. cancer other than skin
cancer within the last 5 years; chronic rheumatological disease, chronic severe
depression) and any condition deemed by the study investigators to limit compliance with
the protocol (e.g. drug abuse).
Participants were recruited from churches and businesses in communities within
San Bernardino County, California. Presentations and flyers about the California
Mission fig study were distributed at churches and business establishments, as well as the
Drayson Center exercise facility at Loma Linda University. Potential subjects were
recruited by flyers that were approved by the university’s Institutional Review Board.
Registration sheets were left at different recruiting sites for individuals and were the basis
for later communications by the researchers. Upon arrival at the scheduled screening
appointments, all study procedures were explained in detail and a signed informed
consent form was obtained from each eligible participant. Only subjects who signed the
consent form were allowed to take part in the study.
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Laboratory Analyses
At each visit requiring blood to be drawn (screening, week 6, week 7, week 11,
and week 12), subjects were asked to fast overnight. Water and standard allowed
medications were to be taken on the morning prior to the visit. Blood samples were
drawn between 7:00 to 10:00 a.m. At screening, one 10 ml red top tube was drawn and
centrifuged. Experienced certified venipuncturists were hired to perform the blood
draws. Samples were sent to the Loma Linda University Medical Center Clinical
Laboratory for analysis of total cholesterol, low density lipoprotein cholesterol (LDL),
high density lipoprotein (HDL) cholesterol, triacylglycerol levels, alanine
aminotransferase (ALT), creatinine and glucose.
At follow-up visits 6, 7, 11 and 12, one red top tube of 10 ml and one 4 ml green
top tube for plasma were drawn. The blood was allowed to cool for about 10-15 minutes
at room temperature before being put on ice. Samples were placed in a cooler and
transported to the Loma Linda University School of Public Health, Nichol Hall Room
1112, where they were separated in a refrigerated centrifuge at 1800 x g and 4 degrees
centigrade. Serum/plasma was aliquoted into vials and kept in a -70 degree Fahrenheit
freezer in Nichol Hall Room 1112A. Frozen samples for CRP analysis were all sent
together at the end of the trial for analysis to the University of California at Davis
research laboratory.
The method employed was a high-sensitivity CRP analysis test. Testing for CRP
at the UC Davis involved a Poly-Chem analyzer from PolyMedCo. Coefficient of
variability (CV) for runs done on 3 sets of controls yielded 5.72%. The rest of the
samples were analyzed for antioxidant capacity in the Nutrition Department laboratory at
50

Loma Linda University by the principal investigator. The two tests that were employed
were the ferric reducing antioxidant power (FRAP) test and total antioxidant capacity
(ABTS). Coefficient of variation for controls analyzed for both tests yielded values that
were less than 10%. ABTS radical is 2,2'-azinobis (3-ethylbenthiazoline-6-sulfonic acid)
and is reduced (decolorized) by antioxidants in the blood. In the FRAP assay, the
antioxidant capacity of the plasma is evaluated as reductance of Fe3+ —> Fe2+, which is
then chelated by tripyridyltriazine (TPTZ) to form Fe2+-TPTZ, which absorbs at 593
nm. Due to the varied chemistry of these two assays, the results do not match exactly.
Dietary Analyses
The Nutrition Data System for Research (NDSR), which is maintained by the
Nutrition Coordinating Center at the University of Minnesota, was the software used to
acquire the 24 hour dietary recall. The recalls were performed by research dietitians
through two phone interviews and one in-person interview per study phase, for a total of
six recalls. The phone interview was completed on a random day between weeks 2 and 4,
weeks 4 and 6, weeks 7 and 9, and weeks 9 and 11. The day was chosen by pulling from
a box containing folded papers labeled Sunday through Friday, after which they were
returned to the box. If the interview was not possible on the drawn day, it was conducted
as soon as possible thereafter. The in-person interviews were completed on the week 4
and 9 visits.
Statistical Analyses
Data entry was done by the principal investigator and a random 10% sample was
re-entered to ensure accuracy. Median and interquartile ranges were presented for Creactive protein and antioxidants, which were not normally distributed and therefore
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were log transformed. However, the non-transformed variables are shown in the tables.
We analyzed both the averaged CRP values for the last 2 weeks of each study phase, as
well as the values obtained on the last visit. Results did not differ substantially (data not
shown), therefore only the averaged values are shown. Student t tests were used to
compare baseline characteristics. Analysis of CRP, antioxidants, and dietary intake was
performed at the end of each study phase utilizing a paired t-test. A general linear model
of repeated measures analysis was also performed to determine if there was a difference
between the participants in the two study phases (group effect) or if there was a
carryover effect of figs between the two study phases (period effect). Software utilized
for analyses was SPSS version 15.0 (SPSS Inc., Chicago, IL, U.S).
Results
Of the 102 participants randomized, 14 dropped out (six from the intervention
group and eight from the control group), six were unwilling to complete the study, two
developed diarrhea, two had family emergencies, two found they disliked figs, one was
placed on cholesterol medication by his physician, and one participant was diagnosed
with a terminal illness. There were 36 females and 15 males who initially started the
intervention phase, while 34 females and 17 males initially started the control phase.
Baseline characteristics were similar between participants randomized first to the
intervention versus the control phase, except for a heart pulse that was 5 bpm higher in
participants starting with the intervention phase (p=0.02) as shown in Table 1. This is
most likely an error caused by the number of statistical tests that were performed for all
the variables.
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Body weight did not change significantly during the intervention phase as
compared to the control phase (p= 0.08). However, female participants analyzed
separately did experience a slight weight gain of 0.5 kg (p=0.01), as shown in Table 2.
Other measurements such as body mass index (BMI) (p=0.06), systolic (p-0.62) and
diastolic (p=0.86) blood pressure, as well as pulse (p= 0.53) were similar between the
intervention and control phases.
As shown in Table 3, mean of averaged CRT values in the intervention phase did
not differ significantly compared to control phase. Mean values were 1.9+ 2.8mg/L
versus 2.1+ 3. Img/L in the intervention and control phases, respectively (p=0.31). The
FRAP antioxidant test result analysis did not show any difference between study phases
(median [interquartile] 0.1 [0.1, 0.2] mmol/L; p= 0.96). The ABTS test results
confirmed the lack of difference between the two phases (median [interquartile] 0.2 [0.2]
mmol/L; p= 0.97), as shown in Table 3. There was also no period effect for CRP (p=
0.69), FRAP test (p= 0.36) or ABTS (p= 0.97) test, as shown in Table 4.
Analysis of dietary intake in Table 5 shows that participants consumed
approximately 187 calories more during the intervention phase (p<0.0001), while
calories consumed from fat were 4% lower (p<0.0001). Also, calories consumed from
carbohydrates were 6% higher (p<0.0001) and calories from protein were 1% lower
(p^O.Ol). Nutrient levels were also different for participants during the intervention
phase versus the control phase. Iron levels were increased by 1.7 mg (p=0.0004) in the
intervention phase, calcium levels were increased by 174 mg (p<.0001), potassium levels
by 584mg (pO.OOOl), magnesium by 56mg (pO.OOOl), and copper by 0.29mg
(p<0.0001).
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Discussion
In this study, consumption of California Mission figs for 5 weeks in participants
with elevated cholesterol levels did not alter CRP values or affect antioxidant levels.
Analyzing CRP values for the last week of each study phase also showed similar results
between the intervention and control phases. Despite eating more calories and more
carbohydrates, participants ate less fat and did not have a significant change in weight.
Participants were well supported throughout the study by having direct and
frequent contact with the study investigators for questions or support, which may have
contributed to the high compliance rates of the study. The intervention was also easy and
inexpensive to administer, which further contributed to the study's success. The
crossover design allowed for the testing of each participant in both study conditions, thus
increasing measurement precision and minimizing variability. Figs in particular have
not been studied before in regards to evaluating their effect on inflammation and
oxidative stress, while other foods with high polyphenol content have been studied.
However, results have been largely inconclusive due to the lack of randomized
controlled trials. Some studies on tea linked intake to an influence on the incidence and
progression of cardiovascular disease and a decrease in body inflammation, but the effect
was attributed largely to mechanisms other than its antioxidant content (Peters, Poole &
Arab, 2001). Cocoa, on the other hand, has been shown to increase antioxidant levels in
the body, as well as increasing anti-inflammatory cytokines (Schramm, Wang & Holt,
2001), but studies done on cocoa consumption were mostly in vitro and there is evidence
suggesting that similar results may not occur in vivo (Spencer, Chaudry & Panna, 2000).
Figs were shown to have excellent polyphenol scores among dried fruit, but they were
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not compared to any of the other known foods that influence inflammation and
antioxidant levels, such as wine, olive oil, and tea. This presents a difficulty in
generalizing effects found in those foods to those associated with fig consumption.
Eating figs consistently for 5 weeks significantly increased mineral levels such as
iron, calcium, potassium, magnesium and copper. This is an important outcome, since
certain populations may be at risk for deficiency in those minerals. For example, young
children, pregnant women, adolescent girls and women of childbearing age may be at
risk of deficiency due to growth spurts or higher iron needs during menstruation (Centers
for Disease Control [CDC], 1998).
In this current study, blood samples were drawn from participants after a 12 hour
fast, which may have led to the lack of significant differences between the two study
phases. According to Osakabe, Baba and Yasuda (2001), the majority of antioxidants are
metabolized from the blood within 8 hours, demonstrating that the antioxidant effect of
food does not last for a long period of time, but is quickly absorbed and cleared by the
body. Sound nutritional recommendation would be to increase intake of fruits and
vegetables that are rich sources of antioxidants and to consume them regularly.
C-reactive protein, even though more stable than other inflammatory markers, is
affected by many conditions and thus predicting its change was difficult. CRP decreased
by 0.13mg/L in the intervention phase which was not statistically significant. There also
seemed to have been extreme values of CRP between participants, but even after
controlling for these extreme values, results remained insignificant. Lack of difference in
CRP values between the intervention and control phase can be attributed to the relatively
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short duration of the study; perhaps in order to affect change the study phase needed to
be longer.
Study Limitations
Lack of baseline values of CRP might have been a major limitation of this study.
However, the crossover design helped eliminate that bias by providing the before and
after picture of each participant. Participants self-selected into the study and therefore
could have had similar characteristics initially, such as better diets and a more consistent
exercise routine, which would decrease the heterogeneity of the sample size. Figs in this
study were not analyzed for their polyphenolic content, therefore there was no
polyphenol reference value to help explain the results obtained. Also figs are not a
popular American fruit, which may have further narrowed the pool of potential
participants.
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141 Screened
18 Low overall lipid values
6 Trig >300
8 No longer interested
4 BMI too high
1 BMI too low
1 Family emergency
1 Hormone replacement therapy
▼

102 Randomized

51 Randomized to Figs

51 Randomized to No Figs
5
1
1
1

1
1
1
1
1
1

Loss to Follow-up
Family emergency
Diarrhea
Disliked Figs

Diarrhea
Cholesterol meds
Severe illness
Family emergency
Disliked figs
Loss to Follow-up

t

45 Completed Study

43 Completed Study
Figure 1. Study Flow Chart
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Table 1. Study Participant Characteristics and Fasting Laboratory Variables at Screening
(n=102)
Intervention (n=51) Control (n=51)
P-value
Age (years)

56.2 + 10.3

54.8 + 11.4

0.52
0.67

Gender
Female

36 (70.6)

34 (66.7)

Male

15 (29.4)

17(33.3)
0.49

Ethnicity
White

19(37.3)

17(33.3)

Hispanic

10(19.6)

13 (25.5)

Carribean

0(0)

3 (5.9)

Black/Hispanic

1(2)

0(.0)

Black

6(11.8)

8(15.7)

Asian

10(19.6)

7(13.7)

5 (9.8)

3 (5.9)

Cholesterol (mg/dL)

203+ 27

205+32

0.77

Triglycerides (mg/dL)

113+59

128+ 60

0.20

High density lipoproteins (mg/dL)

56+ 13

55+ 15

0.78

Low density lipoproteins (mg/dL)

135+ 22

136+ 23

0.77

BMI (kg/m2)

26+3

25+4

0.21

Height (cm)

164.2+9.5

164.3+9.1

0.98

Weight (kg)

72.8+13.0

70.0+13.3

0.29

TSH (mlU/mL)

2.5+ 1.4

2.4+ 1.3

0.77

Glucose (mg/dL)

93+ 13

93+ 11

0.99

Creatinine (mg/dL)

0.9+ 0.3

0.9+ 0.2

0.70

ALT (U/L)

28+ 15

21+ 11

0.08

Systolic blood pressure (mmHg)

125+22

125+ 19

0.98

Diastolic blood pressure (mmHg)

80+ 10

79+9

0.70

Pulse (bpm)

66+ 11

61+9

0.02

Unknown
Screen lipids

± indicates mean + standard deviation
n(%) indicates number of participants and their percentage
TSH: thyroid stimulating hormone, BMI: body mass index, ALT: Alanine Aminotransferase
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Table 2. Descriptive Data for Participants Who Completed Study at Baseline,
Intervention Phase and Control Phase*
N

Baseline

Intervention
Phase

Control
Phase

Difference P-value
between
means

BMI (kg/m2)

84

26.4+ 37

26.6+3.9

26.4+3.7

-0.2

0.06

Body Weight
(kgs) - all

85

71.0+13.4

71.4+14.0

71.0+13.5

-0.4

0.08

Women

65.5+10.4

65.8+10.2

65.3+10.4

-0.5

0.01

Men

82.0+11.9

83.0+13.7

82.1+11.9

-0.9

0.31

Systolic
pressure
(mmHg)

84

125+21

124+ 17

126+33

1.7

0.62

Diastolic
pressure
(mmHg)

84

79+ 10

77+9

76+9

-0.1

0.86

Pulse (bpm)

84

64+ 11

64+ 10

63+ 10

-0.6

0.53

* mean + standard deviation
BMI, weight and blood pressure measurements were missing for 4 participants while 3 participants were
missing only weight measurement.
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Table 3. Mean CRP Levels of the 2 Measurements Taken at the End of Each Study Phase
and Antioxidant Levels Measured at the Last Study Week According to Study Phase.
Control Phase

Intervention Phase

PMedian 25th % 75th % Media 25,h % 75"' %
value*
n
Ql
Q3
Ql
Q3

Outcome
Variables

N

C-reactive

88

1

0.5

2.1

1

0.6

2.1

0.307

FRAP

87

0.1

0.1

0.2

0.1

0.1

0.2

0.957

ABTS

88

0.2

0.2

0.2

0.2

0.2

0.2

0.967

* indicates the p-values for the natural log transformed outcome variables
Blood sample was not available for one participant for the FRAP test
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Table 4. Dietary Intake of Participants in Each Study

Intervention Phase
N

Energy (Kcal)

83

Mean+S
D

Median

1802+

1727.1

Control Phase

25%
Ql

75%
Q3

Mean+
SD

Median

1472.8

2049

1614.8+5

On
4^

83

% Kcalories
Carbohydrate

83

% Kcalories
Protein

83

75%

Ql

Q3

1594.5

1241

1907.6

<0.0001

66.4

513
% Kcalories
Fat

P-Value

25%

25.1

21.9

29.4

29.2+
7.6

28.8

24.5

33.7

<0.0001

64.9+
9

66.9

59.6

70.3

58.5+
8.7

58.9

52.7

64.3

<0.0001

14.5+
3.9

13.5

11.7

16.7

15.6+

14.5

12.3

17.8

<0.01

25+
7

4.7

Table 5. Dietary Mineral Intake of Participants
Intervention Phase
N

Mean+ Median
SD

25%

Control Phase
75%

Ql

Q3

Mean+
SD

Median

25%

75%

Q1

Q3

P-Value

Iron

83

19.8+
11.6

16.7

12.8

22.1

18+
12.5

14.9

9.6

21.3

0.0004

Calcium (mg)

83

1194.2+

1085.8

810.4

1472.7

1019.8+

911.3

601.8

1319.6

<0.0001

522.9

523
Potassium (mg

83

3392.5±
961.8

3346

2685.7

4131.6

2808.4+
1125

2664.9

2032

3448.4

<0.0001

Magnesium(mg)

83

445.7+
1.51

425

354.7

506.3

389.3+
389.3

355.2

272.8

467.6

<0.0001

Copper(mg)

83

2.3+
1

2.1

1.5

2.7

2+
1

1.8

1.3

2.6

<0.0001

O'N
L/l

CHAPTER 5
ADDITIONAL FINDINGS

A. Summary and Implications of Findings
Table 1 presents descriptive data results for study participants randomized to
intervention and control phases. In the two study phases, results revealed similar
characteristics and laboratory values at baseline, with the exception of pulse, which was
5bpm higher in the intervention group. However, this could be a random error that
resulted due to the number of statistical tests performed for all the variables below.
Table 1. Descriptive Data at Baseline, Comparing Intervention Phase to Control Phase

Age (years)

Figs (n=45)

Control (n=43)

P-value

56.1+ 10.5

55.2+11.5

0.71
0.94

Gender
Female

30 (66.7)

29 (67.4)

Male

15(33.3)

14 (32.6)
0.40

Ethnicity
White

16(37.2)

14(31.1)

Hispanic

7(16.3)

12 (26.7)

Carribean

0(.0)

3 (5.9)

Black/Hispanic

1 (2.3)

0(.0)

Black

6(14.0)

7(15.6)

Asian

9 (20.9)

6(13.3)

Unknown

4 (9.3)

3 (6.7)

204+ 30
107+ 59

202+ 27
131+63

Screen Lipids
Cholesterol (mg/dL)
Triglycerides (mg/dL)
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0.77
0.08

Table 1 (Continued). Descriptive Data at Baseline, Comparing Intervention Phase to
Control Phase
Figs (n=45)

Control (n=43)

P-value

High Density Lipoproteins (mg/dL)

57+ 13

55+ 14

0.51

Low Density Lipoprotein (mg/dL)

133+22

135+23

0.67

BMI (kg/m2)

27.0+3.3

25.7+4.0

0.11

Height (ins)

163.9+9.5

163.6+9.3

0.88

Weight (lbs)

72.9+13.3

69.0+13.3

0.18

2.3+ 1.4

2.5+ 1.4

0.71

93.1+ 13.9

92.2+ 8.9

0.71

Creatinine (mg/dL)

0.9+ 0.3

0.9+0.2

0.71

Alanine Aminotransferase (U/L)

22.6+ 7.6

22.2+ 11.9

0.91

Systolic Blood Pressure (mmHg)

126.0+ 23.1

127.3+21.0

0.79

Diastolic Blood Pressure (mmHg)

80.7+ 10.9

79.0+11.0

0.70

Pulse (bpm)

66.3+ 11.6

61.7+9.0

0.04

TSH (mlU/mL)
Glucose (mg/dL)

+ indicates mean + standard deviation
n(%) indicates number of participants and their percentage
TSH: thyroid stimulating hormone, BMI: body mass index, ALT: Alanine Aminotransferase
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C-reactive protein (CRP) is affected by many factors, such as exercise,
medications and obesity. It was important to identify those who had extreme values
(>10mg/L) of CRP and review their chart to see if there were any known conditions that
might have caused this spike. Review of the charts revealed four participants who had
CRP values that were extreme in the study. Two of the participants were on medications
for chronic conditions, such as hypertension and diabetes, which may explain the
increased CRP levels found. The remaining two charts did not reveal any information
reported in the health questionnaires that could explain the high CRP values. The lack of
possible explantions in these two cases could be attributed to the health questionnaires
only inquiring about changes in medical conditions or medications. Other situations,
such as starting an exercise program, that affect CRP levels, might have occurred without
being reported. However, as seen in Table 2, data analyzed without the four extreme
values yielded non-significant differences between the intervention and control phases of
the study.
Table 2. CRP Analysis without Outliers
Outcome
Variables

N

C-reactive
protein
(intervention
phase)

86

1.70+
1.79

C-reactive
protein
(control
ohase)

85

1.50+
1.61

Min

Max

25th %
Ql

75th %
Q3

Pvalue

0.98

0.30

8.68

0.56

2.0

0.67

0.92

0.30

8.94

0.51

1.97

Mean+ Median
SD

Outliers are values 10 and greater
+ indicates mean + standard deviation
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Since analysis of the averaged values for CRP from weeks 4 and 5 did not yield
any significant differences between the study phases, analysis of week 5 values were
carried out. Analyzing the CRP values for week 5 only did not yield any significant
differences between the two study phases either, as is shown in Table 3.
Table 3. CRP Analysis Comparing Week 5 of each Study Period
25Ih %
Max
N Mean+ Median Min
Outcome
SD
Variables
Q1

75lh %
Q3

Pvalue
0.85

C-reactive
Protein
Week?

82

1.88+
3.06

0.94

0.30

22.14

0.52

2.08

C-reactive
Protein
Week 12

84

1.97+
3.10

0.98

0.30

17.17

0.52

1.95

Blood samples were not available for 6 in the first study phase while 4 were missing in the last week of the end of the
study.

Table 4 shows that there was no significant change in CRP and antioxidant levels
between the intervention and control phases that can be attributed to time. Also there was
no significant difference in CRP and antioxidant levels (using the ABTS test) between
those randomized to the intervention or control phase. Group effect for the FRAP test
indicated that there may have been a difference between the groups’ antioxidant level at
randomization since the p-value was borderline significant.
Table 4. General Linear Model Repeated Measures Analysis
ABTS

FRAP

CRP
F-value

P-value

F-value

P-value

F-value

P-Value

Period effect
(Pre- Post)

0.2

0.69

0.8

0.36

0.002

0.967

Group effect

0.2

0.66

3.7

0.06

0.01

0.164

Group *Perio
d Interaction

0.2

0.70

0.2

0.69

2.0

0.158
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In this study participants were required to consume a total of 120g of figs
everyday during the five weeks of the intervention phase. Table 5 demonstrates that the
average grams of figs consumed by participants during the intervention phase were
126.34g and 0.19g during the control phase per 24 hour period. This reveals high
compliance rates with study protocol. This successful adherence of the participants to the
study protocol can serve as a positive model for other studies of whole food consumption
requiring similar procedures.
Table 5. Average Grams of Figs per Recall
No. of
Observations

Mean+SD

Median

Intervention

235

126.3+40.8

134.40

Control

243

0.19+2.2

0

Phase

25%
Q1
109.20

75% Q3
151.20

0

0

The study protocol called for obtaining 3 dietary recalls per study phase, for a
total of 6 recalls for the study. Table 6 demonstrates that of the 83 participants who
completed 2 or more dietary recalls, 71 completed all 6 and 1 person completed only two.
The maximum number of recalls required was successfully obtained in 85% of
participants.
Table 6. Number of Recalls Completed
Cumulative Cumulative
Frequency
Percent

Number of recalls

Frequency

Percent

2

1

1.2

1

1.2

3

1

1.2

2

2.4

4

3

3.6

5

6.0

5

7

8.4

12

14.5

6

71

85.5

83

100.0
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Table 7 shows the number of recalls completed per study phase. As indicated
below, more participants successfully completed the 3 required dietary recalls in the
control phase than in the intervention phase (78 versus 73 participants).
Table 7. Number of Recalls per Phase
Total

Number of Recalls

Study Phase
1

2

3

Frequency

4

6

73

83

Percent

2.41

3.61

43.98

50

Frequency

1

4

78

83

Percent

.60

2.41

46.99

50

Frequency

5

10

151

166

Percent

3.01

6.02

90.96

100

Intervention

Control

Total

Table 8 shows the frequency of recall according to the day of intake. Results
show that there were almost twice as many recalls done during the weekdays than there
were on the weekend. This confirms high adherence to the study protocol that called for
obtaining two weekdays and one weekend day recalls per study phase, for a total of 6 for
the study.
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Table 8. Distribution According to Day of Intake
Study Condition

Weekday

Weekend

Total

157

78

235

32.85

16.32

49.16

161

82

243

33.68

17.15

50.84

318

160

478

66.53

33.47

100

Intervention
Frequency
Percent
Control
Frequency
Percent
Total
Frequency
Percent

Table 9 shows that fig intake did not differ significantly by kcalories or grams of
figs consumed between participants in the intervention or control phase.
Table 9. T-test for Difference in Intake Between the Two Study Phases
T-Tests
Difference

DF

t-value

P-value|

gramweekend - gramweekday

80

0.15

0.8823

kcalweekend - kcalweekday

80

0.88

0.3811
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CHAPTER 6
CONCLUSIONS

A. Summary and Limitations
Despite being an excellent source of polyphenols, figs did not affect CRP or
antioxidant levels in the body in participants with elevated cholesterol values. Mineral
values for iron, magnesium, potassium, calcium and copper were significantly higher
during the intervention phase than the control phase. Also analysis of systolic blood
pressure values showed a decrease of 2 mmHg between the two study phases that,
although not statistically significant, might have a clinical significance that warrants
further investigations. During the intervention phase, participants were asked to
incorporate a package of figs in their habitual diet at each meal every day for 5 weeks.
Since each package was 330 kcalories, weight gain was a concern.
Despite consuming more calories overall, there was no significant overall weight
gain between the participants in the two phases. This finding can be attributed to the fact
that participants mostly consumed the additional calories from carbohydrates and not
from fat and protein. Carbohydrate kcalories are more readily available to be used as fuel
and thus are utilized by the body for energy first while fat consumed is usually stored.
Weight analysis for females showed a slight but significant gain of 0.5kg during the
intervention phase. Since weight gain is one of the factors affecting CRP levels, it might
have counteracted the effects of the figs. However, further studies are needed to support
this conclusion.
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This study had several limitations. Participants self-selected into the study, and might
have had better diets and exercise routines, thus somewhat limiting our ability to
generalize. However, randomization would have addressed any systematic differences
between the two study conditions thereby at least assuring internal validity. In addition,
polyphenol content of the California mission figs consumed in this study was not
evaluated. This introduces the possibility that the quality or quantity of the polyphenols
in the figs themselves might have been the reason the study phases did not show
significant differences. In addition, the absence of baseline data for CRP and antioxidant
levels might have been considered a limitation had the design not been a crossover,
providing the before and after effect of the intervention variable.
B. Future Studies
The knowledge gained through the process of this study necessitates its
replication using different measurement methodology. In this current study, blood
samples were drawn from participants after a 12 hour fast, which may have led to the
lack of significant differences in antioxidant levels between the two study phases.
According to Osakabe, Baba and Yasuda (2001), the majority of antioxidants are
metabolized from the blood within 8 hours of consumption. Therefore, direct antioxidant
capacity measurements might not have been the optimum measurement method. Urine
analysis or direct oxidized LDL measurements, though more costly, might have yielded
more reliable results.
While antioxidant levels needed to be assessed within a shorter period of
time after ingestion, more time might have been needed to allow for change to occur.
Perhaps future studies assessing the effects of fig consumption on CRP should examine
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changes within different durations. Furthermore, to offset the issue of weight gain that
might occur due to the long term consumption of higher calories, future studies could
decrease the grams of figs consumed daily.
As mentioned earlier, we observed that there was a 2 mmHg difference in blood
pressure observed between the two study phases that should be taken into consideration.
Although this difference was not statistically significant, it might have some clinical
implications. Thus further studies are warranted in this area to determine the effects of
figs on systolic blood pressure through the actions of polyphenols, fiber, both or another
factor altogether. This study analyzed quantitative data only, therefore, to gain
additional information and a wider perspective, future studies should include qualitative
data as well. For instance, health questionnaires completed by participants can be used
to evaluate levels of satiety during the intervention phase and the control phase, as well
as the effect of fig consumption on bowel movements. Analysis of fig intake showed
that it was possible for participants to consistently eat the same food with each meal
successfully for 5 weeks (Table 4), allowing for the possibility that future studies can
conduct similar protocols. Also, the relationship between cholesterol levels and CRP
values was not explored in this study due to time and financial restrictions. However,
there is enough evidence to suggest that elevated cholesterol levels might raise CRP
levels and thus a correlation between the two variables should be investigated.
C. Conclusions and Implications
Figs consumed for 5 weeks did not affect CRP or antioxidant levels in
participants with elevated cholesterol levels. Despite this finding, figs significantly
increased mineral values, including iron, calcium, magnesium, potassium and copper.
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This is important because these minerals are essential to healthy lifestyles and disease
prevention. Finally, this study also showed that studies with foods that increase caloric
intake as well as carbohydrate intake can be done without significant weight gain and
with high compliance. This holds implications for future studies with figs and other
foods.
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APPENDIX B: INFORMED CONSENT
The Effects of Consumption of California Dried Mission Figs on Serum Lipid
Concentrations in Hyperlipidemic Adults
Purpose and Procedures
You are invited to participate in a research study because your blood cholesterol is not
optimal. The purpose of this study is to identify whether eating California dried mission
figs three times daily with meals for five weeks lowers total cholesterol and low density
lipoprotein (LDL) cholesterol in adults with above optimal, borderline or high cholesterol
levels.
At the first visit you need to be fasting. You will be asked questions about your health
history and your blood lipids, glucose and liver function will be measured. We will check
if you meet the requirements for participation. If you do, we will call you up to arrange
the next visit. At this visit you will be assigned through chance to start eating 1 portion
(1/4 cup) of prepackaged California dried mission figs with your meals three times daily
for 5 weeks OR to continue your usual diet. If you start with the figs, after five weeks you
will return to your usual diet. If you start with your usual diet, after five weeks you will
start eating figs as described above. Figs will be provided at no charge.
The study involves 8 visits in the course of the 12 weeks. The purpose of the visits is to
deliver the figs and take blood tests. All the study visits are required. There will be blood
drawings after 4 and 5 weeks and again after 11 and 12 weeks of the study. This adds up
to a total of 5 blood drawings. At each blood drawing two tubes of blood totaling 5
tablespoons will be obtained. The results of the blood tests after the first one will not be
available until after the end of the study.
We will measure your body weight, waistline and blood pressure at 6 of the 7 study
visits. You will be asked to report your food intake during the last 24 hours on 6
occasions. On 4 of these occasions you will be called up at home by a dietitian for a
telephone report. The other two reports will be done during site visits.
Who can take part
Men and women aged 25 to 75 years with LDL cholesterols that are in the above optimal
(100-129 mg/dL), borderline (130-159 mg/dL) or high (160-189 mg/dL) range can take
part. If your cholesterol is treated with medications you cannot take part. If your
cholesterol is in the high range, we need the permission of your physician. If you have
other diseases that are the cause of your high cholesterol you cannot take part. If you
have type 1 diabetes, type 2 diabetes that is not well controlled or use certain medications
you cannot take part.
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Risk
Pain and minor bruising at the site of the needle insertion and possible lightheadedness
upon arising after the blood is drawn are possible complications of blood drawing. The
committee at Loma Linda University that reviews human studies (Instituional Review
Board) has determined that participating in this study exposes you to minimal risk.
Benefits
You may not receive any direct benefit from participating in this study. You will be told
your cholesterol levels and receive dietary advice about lowering blood cholesterol. The
dietary changes including figs may lead to lower blood cholesterol. The benefit to
humanity is an understanding of whether a simple dietary change (eating dried figs) can
lower blood cholesterol.
Participants ’ Rights
Your participation in this study is voluntary. Your decision whether or not to participate
or terminate at any time will not affect your present or future medical care. If you decide
to stop, please inform the study investigator.
Confidentiality
All of the information that is collected in this study will be kept strictly confidential.
Information that we collect will be assigned linking codes. All this information will be
stored separately from your name and other personal data. Only the primary investigator
will have linking access. Any publication resulting from this study will refer to the
participants as a group.
Additional Costs/Reimbursement
You will be given free figs for the duration of the study. There is no cost to you for
participating in this study. The blood tests will be performed at no cost. There is a modest
monetary compensation of $25.00 for your effort upon completion of the study.
Impartial Third Party Contact
If you wish to contact an impartial third party not associated with this study regarding any question or
complaint you may have about the study, you may contact the Office of Patient Relations, Loma Linda
University Medical Center, Loma Linda, CA 92354, or call the Office of Patient Relations at (909) 5594647 for information and assistance.
Informed Consent Statement
I have read the contents of this consent form, and have listened to the verbal explanation given by the
investigator. My questions concerning this study have been answered to my satisfaction. I hereby give
voluntary consent to participate in this study. This consent does not waive my rights, nor does it release the
investigators, institution, or sponsors from their responsibilities. I may call the graduate student
investigator, Joycelyn M. Peterson or the faculty advisor, Serena Tonstad, MD PhD at Loma Linda
University, Department of Health Education & Promotion during routine office hours at (909) 558-4741 if I
have additional questions or concerns. I have been given a copy of this letter for future reference.
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Subject name (print)

Signature subject

Date

Witness name (print)

Signature witness

Date

I have reviewed the contents of the consent form with the person signing above. I have
explained potential study risks and benefits.

Serena Tonstad, MD PhD
Department of Health
Education & Promotion
Loma Linda University
(909) 558-4575

Joycelyn M., Peterson MPH, RD
Department of Health
Education & Promotion
Loma Linda University
(909)558-8577

Rasha Abdrabou, MPH
Department of Health
Education & Promotion
Loma Linda University
(909) 558-8577
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APPENDIX C: GANNT CHART
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APPENDIX D: STUDY BUDGET
Fig concentrate
(4oz x 90 days = 360)
100 subjects = 72,000 oz (4,5001bs )

Fig Advisory Board

Fig cost and freight by CAL. Fig Advisory Board.
Blood samples (screening period)
$3,375.00

$27.00 each XI25 participants
Four blood samples
$15.00each x 4 = $60.00 x 100 subjects

$6,000.00

2Phlebotomist @$17.00 per hr for 36 hrs

$1,224.00

Already paid

Computer software to analyze diets (2)
Statistician
UC Davis Laboratory fees for CRP analysis

$14,650.00

2 Dietitians at $17.00 per hour x 300 hrs

$10,000.00

Statistician

$2,830.00

Compensation for each subject ($25.00 x 100)

$2,500.00

Estimated University cost for use of facility and equipment
at Drayson Center 6 sessions by $100.00 per session

$600.00

Recruitment for 100 participants 500 flyers

$500.00

Misc.

$600.00

$42,279.00

Grand total
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APPENDIX E: PARTICIPANT QUESTIONNAIRE (BASELINE)

LOMA LINDA UNIVERSITY
FIG RESEARCH STUDY
Welcome to the fig research study! Please take a few minutes to complete the following
questionnaire. It will be used to facilitate information only and does not represent a
diagnostic evaluation. If you are uncomfortable answering any of these questions, leave
them blank. Thank you for taking the time to fill out this questionnaire.
Date of Birth:

Name:
Gender (please circle): Male or Female

Ethnicity (please circle): Asian, Black (African American or Caribbean), Hispanic,
White
Telephone number:
(Home):

(Work):

(Cell):

Mailing Address:

Email address and fax:
I. Are you under medical care for any of the following conditions or diseases? If yes,
please circle
High blood pressure
arteries)

Angina pectoris (chest pain due to blocked

Stroke

Blocked arteries in legs

Diabetes type 2
arteries

Heart attack or surgery for blocked coronary

Gallbladder disease

Diverticulosis

Irritable bowel syndrome

Heartburn or esophageal reflux

Cancer (write in what type
Family history of high cholesterol

) Thyroid disease
High blood cholesterol
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Food allergies or intolerances (please write in)

Other:

B. Please list all current medications, pain meds, vitamin or other supplements, and over
the counter meds that you are taking at present

C. What has been your highest cholesterol reading?
Approximate date:
What was your most recent cholesterol reading?
Approximate date:
Are you taking medication to lower cholesterol (within the last two months) Circle
Yes or No
D. Do you engage in any regular physical activity? Circle Yes or No
What type and how often?_

E. Do you smoke? Circle Yes or No
If yes, for how long and how much
If you quit smoking within the past year, please write the date:
Signature
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APPENDIX F: SHORT HEALTH HISTORY QUESTIONNAIRE
Have there been any changes in your medical condition since the start of the study?
No
Yes
If yes, describe.

Have there been changes in your use of medication since the start of the study?
No
Yes
If yes, describe.

At crossover or final visit:
On a scale of 1 to 10, with 1 indicating not at all, and 10 indicating very much, how well
do you like eating the provided figs three times a day?
Very much
123456789 10
Not at all
Have you noticed any effects of figs on your overall health?
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APPENDIX G: COMPLIANCE SHEET
LOMA LINDA UNIVERSITY SCHOOL OF PUBLIC HEALTH
FIG COMPLIANCE SHEET
Dear Participant,
Please take the time at the end of each day to circle Yes or No for each meal in the boxes
provided below, to indicate whether or not you ate the required amount of figs. Begin at
the first week (one) to the fifth week (five)
Thank you for taking the time to fill out the compliance sheet.
Any questions please call your research interventionist Joy Peterson at 909-261-0359,
or email tojoysfigresearch@yahoo.com
Circle in the box at the end of each day: (Yes) or (No)
Week

Sunday

Monday

Tuesday

Wednesday

Thursday

Friday

Saturday

One
Breakfast
Lunch
Dinner

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Two
Breakfast
Lunch
Dinner

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Three
Breakfast
Lunch
Dinner

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Four
Breakfast
Lunch
Dinner

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Five
Breakfast
Lunch
Dinner

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No

Yes/No
Yes/No
Yes/No
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APPENDIX H: 24 HOUR DIET RECALL
24-Hour Dietary Recall Collection
The NCC Service Center has extensive expertise and experience in conducting 24-hour
dietary recall interviews via telephone with a variety of populations, including children.
Trained and certified NCC staff will train the study dietitian to conduct the 24-hour
dietary recall interviews. Interviews take place over the telephone using NDSR, and are
conducted by Joycelyn Peterson. Because dietary practices have been found to vary by
time of week, interviews are scheduled to capture both weekend and weekday intakes.
The NDSR multiple-pass interview methodology allows the respondent repeated
opportunities to recall their intake within the past 24 hours and to provide detailed food
descriptions. Food portion estimation visual aids are provided to respondents to assist in
portion size estimation.

Contact person is Mary Stevens at 612.626.9428 or
steve004@umn.edu for more information.
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APPENDIX I: COMMON SWEET SNACKS AND DESSERTS CONTAINING «
330 KCALORIES.
Three servings of figs = 330 kcalories

Type

Serving size

kcalories

4 oz
4 oz
4 oz
3 oz
3 oz
4 oz
4 oz
3 oz
6 oz

350

Chocolate chip
Oatmeal
Oreo
Pound cake
Brownie
Two fig bars
Apple pie
Carrot cake
Granola bar
Three Musketeers candy bar 3 oz
Ice cream
4 oz

360
320

330
350
320
340
350
360
360
420
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APPENDIX J: TOTAL ANTIOXIDANT CAPACITY (ARTS) TEST PROTOCOL
Total Antioxidant Capacity (ARTS)
Procedure
1. Prepare ARTS solution (see below)
2. Dilute plasma samples 1:5
(Vortex thawed samples and centrifuge for 10 min. at 3500 rpm)
50 pi plasma + 200 pi PBS (saline)
3. Prepare plate with 20 pi blank (PBS), standard, or sample
4. Set plate reader as follows:
Temperature: 37* C
Dispense 180 pi ABTS solution
Delay for 3:30 minutes
Shake: Medium for 0:30 seconds
Read: 734 nm
Solutions
1. Trolox Stock Standard - 2.0 mmolar in ethanol
FW = 250.29
g = 0.002 x 250.29 x 0.1 = 0.050
To make 100 ml:
Weigh 0.050 g (50 mg), add to 100 ml ethanol
Portion into screw-cap vials and keep in -80* freezer
Working standards:
PBS
Stock standard
2 ml
STD 1 (0.4)
0.5 ml (500 pi) Stock standard
1 ml
STD 2 (0.2)
1 ml (1000 pi) STD 1
1 ml
STD 3 (0.1)
1ml STD 2
1 ml
STD 4 (0,05)
1 ml STD 3
2. ABTS solution (50 ml)
ABTS (FW = 548.68)
g = 0.23 x 548.68 x 0.1 = 0.0126 g
AAPH (FW = 271.2)
g = 0.23 x 271.2 x 0.1 = 0.0062 g
Add ABTS and AAPH to 50 ml buffer solution. Heat to between 60 and 70*C
and hold for 20 minutes (solution should turn a dark blue color). Allow reagent
to cool to room temperature before using in assay. The solution should be used
the day it is prepared; 50 ml is sufficient for 2 plates.
3. Sodium phosphate buffer
Add 3.1 g NaH2P04*H20 and 10.9 g Na2HP04 (anhydrous) to boiling distilled
water to make up 1 L of solution. The pH of the final solution should be 7.4.
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APPENDIX K: FERRIC REDUCING ANTIOXIDANT
POWER (FRAP) TEST PROTOCOL
Synergy- Ferric Reducing Antioxidant Power Assay (FRAP)
11-12-08
Benzie IF and Strain JJ. Methods Enzymol. 299(1999): 15-27.
Reagent Preparation
Solutions for the FRAP reagent
1) Prepare 100 ml of lOmM Tripyridyltriazine (TPTZ) in 40 mM HC1:
Mix
0.312g of TPTZ
0.324ml of HC1 (325pl)
and distilled H20 in an Erlenmeyer flask to make up 100ml of solution.
2) Prepare 100ml solution of 20mM FeCB 6H20:
Mix
0.54g of 20mM FeCl3 6H2Q
and distilled H20 in an Erlenmeyer flask to make up 100ml of solution.
3) Prepare 1000ml solution of 300mM acetate buffer, pH 3.6:
Mix
3.1g of sodium acetate 3 H20
16ml glacial acetic acid
and distilled H20 in an Erlenmeyer flask to make up 1000ml of solution.
FRAP Reagent:
Mix solutions 1, 2, & 3 together (Ratio: 10:1:1 of buffenTPTZTeCls)
Wrap final solution in foil and store in below room temperature conditions until actual use.
Standards
1) Trolox Stock Standard (0.002M)
Trolox is 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (FW 250.29)
To make 100ml of Stock Standard,
G = 0.002 x 250.29 x 0.100 = 0.05Og
Weigh out 0.050g Trolox and mix with 2ml of ethyl alcohol. Add distilled H20 to make
up 100ml in volumetric flask. Portion into 2ml vials and store in freezer at - 70°C until
use.
2) Trolox Working Standards
Dilution 5:1
2ml Trolox + 8ml distilled H20 (10ml
Level 4
total)
1ml level 4 + 1ml distilled H20
Level 3
1ml level 3 + 1ml distilled H20
Level 2
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Dilution 10:1
SOOpl Trolox + 9.5ml distilled H20
(10ml total)
1ml level 4 + 1ml distilled H20
1ml level 3 + 1ml distilled H20

Plasma dilution
Dilution 5:1
IOOjj.1 plasma + 400pl distilled H20

Dilution 10:1
IOOjliI plasma + 900pl distilled H20

Synergy set-up
Measurement mode: Abs
Reaction mode: End-point
Blank: Reagent
Wavelength: 593nm
Temperature: 37°C
Standard/sample volume: 20pl
Reagent volume: 200|il
Shake: 5 minutes and read at 5 minutes
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